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Abstract 
Hypertension is a global health issue with over one billion people affected worldwide. The 
etiology is likely due to a combination of genetic, environmental and lifestyle factors. Current 
evidence supports lifestyle modification either as stand alone or adjunct therapy. However, 
evidence is lacking in how to approach lifestyle modification in the primary care setting. 
Motivational interviewing (MI) is one technique that has shown promise in diverse clinical 
settings. The purpose of this literature review is to address the utility of using MI in primary care 
with hypertension. Using a comprehensive approach, a literature search was conducted which 
included the following databases: CINAHL, Medline OVID, PUBMED, and COCHRANE 
Reviews, as well as applicable guidelines. Eight papers were selected for inclusion. A critical 
appraisal of the literature revealed that MI has clinical utility when addressing lifestyle 
modification in the context of hypertension in primary care. However, there are large 
methodological gaps illustrating the necessity for further research. 
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Chapter I: Introduction 
 Hypertension places a vast burden on individual health and the healthcare system, largely 
due to its direct relationship to cardiovascular disease, cerebral vascular disease, peripheral 
vascular disease, chronic kidney disease, and death (Daskalopoulou et al., 2015; Public Health 
Agency of Canada [PHAC], 2010). As per the PHAC (2010), in 2007 hypertension accounted for 
21.1 million patient visits to a physician, making it the most common reason to see a doctor. In 
addition, a Canadian population-based cohort study estimated the cost of hypertension in 2010 at 
13.9 billion dollars, with a projected increase to 20.5 billion dollars by 2020 (Weaver et al., 
2015). Despite the significance of this data, hypertension is often a silent disease that can be 
perceived as benign, despite its potential to cause insidious damage (Hammer & McPhee, 2014; 
Wang & Ramachandran, 2005). However, the current evidence reflected in national and 
international hypertension treatment guidelines (Daskalopoulou et al., 2015; James et al., 2014; 
World Health Organization [WHO], 2003) recommend that hypertension, at least in the early 
stages, may be controlled with lifestyle modifications such as weight loss, dietary changes, 
exercise, and stress reduction. 
 Although there is pharmacological treatment for hypertension, medications have the 
potential for multiple side effects and interactions. Furthermore, many of the modifiable risk 
factors for hypertension are the same risk factors implicated in other cardiovascular and chronic 
diseases such as coronary artery disease, congestive heart failure, type II diabetes, and metabolic 
syndrome (Fisher et al., 2011). As such, non-medical approaches to hypertension management 
should also be considered. Family nurse practitioners practice within a mandate of primary 
healthcare, and as such recognize the value of emphasis on lifestyle modification in collaboration 
with their clients. As part of this, strategies to support behaviour change could be used to modify 
	 2	
risk factors and improve clinical outcomes. Motivational interviewing (MI) is one therapeutic 
approach that could be employed in the primary care setting when addressing lifestyle 
modification within the context of essential hypertension.  
 The aim of this project is to answer the question, “Is MI within a primary care context an 
effective method in eliciting change relating to modifiable risk factors associated with 
hypertension?” To address this, a comprehensive review of the literature will be undertaken. To 
contextualize this further, an overview of hypertension along with the associated modifiable risk 
factors, behavioural counselling, nurse practitioners, and primary care will be first presented to 
illustrate the significance and relevance of this issue in practice. Following the background, the 
review methods and findings of this comprehensive literature review will be presented.  
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Chapter 2: Background 
 One in five Canadian adults have hypertension and one in six Canadians are unaware of 
being hypertensive (Robitaille et al., 2012).  It is estimated that by eliminating hypertension, the 
incidence of strokes would be decreased by 35% and the incidence of heart attack would be 
decreased by 18% (Warburton, Charlesworth, Ivey, Nettlefold & Bredin, 2010), which would 
undoubtedly increase quality of life and reduce healthcare expenditures. The following section 
will discuss the definition and pathophysiology of blood pressure and hypertension followed by a 
discussion regarding lifestyle modification and MI within the context of hypertension in the 
primary care setting.  
Definition of Hypertension 
 Hypertension, as defined by The 2015 Canadian Hypertension Education Program 
Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, 
and Treatment of Hypertension (CHEP) (Daskalopoulou et al., 2015), is a systolic reading 
greater than 135 mmHg and a diastolic reading greater than 85 mmHg in serial daytime readings. 
Ideally, as per current guidelines, hypertension is measured using an ambulatory blood pressure 
monitor or as home blood pressure measurements. If ambulatory or home blood pressure 
monitoring is unavailable, hypertension is diagnosed by repeated elevated blood pressures 
greater than or equal to 140/90 mmHg within three to five office visits (Daskalopoulou et al., 
2015). The exception to this is if the blood pressure is greater than or equal to 180/110 mmHg on 
the first visit, thus signifying hypertensive urgency that is treated as an emergency and would 
require immediate review and management.  
 Hypertension is further broken down into stages; prehypertension, stage one hypertension, 
and stage two hypertension. Prehypertension is defined as a systolic reading between 120-139 
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mmHg or a diastolic reading between 80-89 mmHg. Stage one hypertension is defined as a 
systolic reading between 140-159 mmHg or a diastolic reading between 90-99 mmHg; and stage 
two hypertension is a systolic reading greater than or equal to 160 mmHg or a diastolic reading 
greater than or equal to 100 mmHg (Basile & Bloch, 2014). Hypertension may be systolic and 
diastolic or isolated systolic or diastolic and typically depends on age. In younger adults, 
diastolic hypertension prevails because the mechanism is most often a high cardiac output as 
opposed to increased peripheral vascular resistance. In those 50 and older, systolic hypertension 
is more common because the mechanism is usually an increase in peripheral vascular resistance 
due to prolonged excess stress on the vasculature with a decrease in the effect of cardiac output 
most likely due to left ventricular hypertrophy (Lee, Williams & Lilly, 2011). 
Prevalence 
 Hypertension is already the most common reason to see a physician in Canada (PHAC, 
2010) and the percentage of hypertensive adults is predicted to increase by 60% within the next 
20 years (Hermann, Flammer & Luscher, 2006). The PHAC (2010) reports data on hypertension 
gathered via the Canadian Chronic Disease Surveillance System (CCDSS), a collaborative 
network between provinces and territories linking the health insurance registry databases to 
physician billing and hospitalization databases. In 2009, the CCDSS expanded its scope to track 
the prevalence of hypertension. The criteria for inclusion in the registry are two or more 
physician claims within two years or one inpatient hospital separation abstract listing 
hypertension as a diagnosis using the ninth or tenth international classification of disease codes 
(2010). Cases are excluded if the hypertension is pregnancy-induced or is categorized as 
pulmonary hypertension. Other exclusions include groups or facilities under federal jurisdiction, 
such as federal correctional facilities, full-time employees of the Canadian Forces, and members 
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of the Royal Canadian Mounted Police. The CCDSS reports the incidence of hypertension in 
2006/2007, as being 22.7 % or greater than one in five adult Canadians 20 years of age or older. 
Furthermore, they state this does not account for the estimated 17% of adults unaware of being 
hypertensive (PHAC, 2010).  
 Statistics Canada (2015) cites different numbers but their statistics are gathered from the 
Canadian Community Health Survey (CCHS), which collects self-reported health data at sub-
provincial levels of geography. Initially data was collected every two years with 130,000 
participants but changed to annual collection of 65,000 people in 2007. In 2011, Statistics 
Canada (2013) states that 17.6% of Canadians 12 years of age or older reported having 
hypertension, which represents no significant change from 2010. Statistics Canada (2015) covers 
the population in ten provinces and three territories and excludes people living on reserves and 
other Aboriginal settlements in province, full-time members of the Canadian Armed Forces, 
institutionalized populations and two Quebec health regions. They state that this exclusion 
represents less than 3% of the Canadian population.  
  Statistics Canada (2013) and the PHAC (2010) both include gender differences when 
addressing the prevalence of hypertension. The PHAC reports similarities in age-specific 
prevalence rates between male and females up to age 50 with rates for hypertension in woman 
increasing after the age of 55. Statistics Canada reports that males within the age groups 35-44 
and 55-64 had higher rates of hypertension but at ages 75 and older, female rates were higher 
than males. Furthermore, rates increased for each successive age group for females but stopped 
for males at 65.  
 The main difference between the above sources of statistics is that the CCHS is self-
reported whereas statistics from PHAC only include individuals diagnosed with hypertension. It 
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is suggested that self-reporting rates may be lower and this is reflected in the self-reported rate 
for 2007/08 through the CCHS as 19.4% versus the CCDSS rate for 2006/07 of 22.7%. It is 
postulated that this is due to people believing that their hypertension has been cured through 
medication or lifestyle changes (PHAC, 2010).  
 In 2008, the worldwide prevalence of diagnosed hypertension in adults 25 years of age 
and above was 40%. This had increased from 600 million in 1980 to one billion in 2008 (WHO, 
2013). As per the WHO (2013), this increase is attributed to population growth, aging, and 
behavioural risk factors such as an unhealthy diet, harmful use of alcohol, lack of physical 
activity, excess weight, and exposure to persistent stress. The highest prevalence of hypertension 
is in the African Region at 46% of adults and the lowest prevalence is in the Americas at 35% of 
adults, illustrating a discrepancy between high and low income countries (WHO, 2013).  
Pathophysiology 
 As per Lee et al. (2011), blood pressure is measured by a manometer reading using 
millimetres of mercury (mmHg) to measure the flow of blood through the arteries. Blood 
pressure is calculated by multiplying cardiac output by total peripheral resistance. Cardiac output 
is determined by the heart rate in beats per minute and stroke volume or the amount of blood 
ejected from the heart with each beat (Brashers, 2010). This is determined by cardiac 
contractility, the preload (venous return to the heart), and afterload (the resistance the left 
ventricle must overcome to eject blood into the aorta). With each heartbeat, there are two phases 
known as systole and diastole, which correspond to the systolic blood pressure and the diastolic 
blood pressure. Systole occurs when the cardiac muscle contracts with a strong enough force to 
pump blood out of the left ventricle into the aorta to be dispersed throughout the body. Diastole 
occurs when the left ventricle relaxes allowing blood to fill the chamber in preparation for 
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systole. Peripheral vascular resistance (PVR) is the resistance or opposition that the heart must 
pump against in order to supply oxygenated blood throughout the body. Although many 
variables affect PVR, in the context of the cardiovascular system, it is mainly the diameter of 
blood vessels that will affect blood pressure because the length of the vessels remains relatively 
constant (Brashers, 2010).  
 Blood pressure can change and react to a broad range of internal and external stimuli, 
including fluid balance, blood flow, heart and renal function, stress, diet, medications, and 
physical activity. The body monitors blood pressure via the kidneys and the baroreceptor reflexes 
in the walls of the aortic arch and the carotid sinuses. A body in homeostasis regulates blood 
pressure using four systems: the heart that supplies pumping pressure, the blood vessels whose 
tone determines systemic resistance, the kidney which regulates blood volume, and many 
hormones which help to regulate all of these systems above (Lee et al., 2011). Each mechanism 
employs a complex set of responses to control blood flow, fluid balance, and heart rate. These 
systems typically work in harmony to maintain a stable blood flow and thus blood pressure. 
 The baroreceptor reflexes are not involved in long-term maintenance of blood pressure 
but fine-tune it moment-by-moment. Receptors are located in the walls of the aortic arch and 
carotid sinuses and sense changes in stretch. If arterial pressure rises, receptors in the aortic arch 
send impulses via the vagus nerve to the central nervous system (CNS) and receptors in the 
carotid sinus send impulses via the glossopharyngeal nerve to the CNS (Lee et al., 2011).  A 
negative feedback system responds by dampening the sympathetic nervous system and exciting 
the parasympathetic nervous system. The parasympathetic system acting through the 
neurotransmitter acetylcholine binding to parasympathetic receptors on blood vessels and in the 
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heart lowers peripheral vascular resistance and cardiac output (Rang, Dale, Ritter, Flower & 
Henderson, 2012). 
 If the renal system detects a drop in perfusion pressure, the juxtaglomerular cells of the 
afferent arterioles in the nephron release renin. Renin causes angiotensinogen, which is produced 
in the liver, to convert to Angiotensin I and then Angiotensin converting enzyme (ACE), 
produced and released by the lungs, causes angiotensin I to convert to Angiotensin II. 
Angiotensin II acts on the vascular system to induce systemic vasoconstriction and on the 
kidneys to increase sodium reabsorption at the proximal convoluted tubule, thus also causing a 
passive increase in water reabsorption. Angiotensin II also acts on the adrenal glands to produce 
and secrete aldosterone, which further increases sodium reabsorption in the distal tubule and 
collecting duct of the nephron. The Renin-Angiotensin-Aldosterone System (RAAS) is essential 
to blood pressure homeostasis and if the cardiac output or the total peripheral resistance increases, 
the kidneys have the ability to return blood pressure to normal by reducing intravascular volume 
through excretion of sodium and water. This mechanism, termed pressure natriuresis, becomes 
less sensitive in hypertensive patients and requires higher pressures to respond (Brashers, 2010; 
Lee et al., 2011). At least two mechanisms may be responsible for this decreased sensitivity: 
First, microvascular and tubulointerstitial injury within the kidneys impairing sodium excretion 
and secondly, a defect in hormonal factors related to the RAAS (Lee et al., 2011).  
 Primary Hypertension. Blood pressure is classified as primary or secondary, with 90-
95% of cases falling within the primary category (Brashers, 2010). Primary hypertension is a 
diagnosis of exclusion and thought to be a result of multiple compounding genetic and 
environmental factors. Whilst no definite genetic markers have been found, several loci on genes 
represent positive associations such as “defects of renal sodium channels and polymorphisms in 
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the gene for angiotensinogen” (Lee et al., 2011, p. 305). Other experimental findings associated 
with primary hypertension include sympathetic overactivity of the heart and blood vessels 
causing an increase in cardiac output and PVR; abnormalities in the regulation of vascular tone; 
ion channel defects affecting the vessels and kidneys; defects in regulation of renal blood flow; 
and inappropriate hormonal regulation (Brashers, 2010; Lee et al., 2011). Insulin may also play a 
role in hypertension as it is postulated that people with type two diabetes or obesity that have 
insulin resistance and subsequent high serum glucose levels will release more insulin. This 
hyperinsulinemic state may contribute to hypertension “via increased sympathetic activation or 
by stimulation of vascular smooth muscle cell hypertrophy, which increases vascular resistance” 
(Lee et al., 2011, p. 306). Obesity is also strongly associated with hypertension. Adipocytes, or 
fat cells, secrete leptin, which under normal circumstances helps to control body weight through 
appetite inhibition and fat deposition. However, this function goes awry in obese individuals as 
chronically high levels of leptin have been found to increase sympathetic nervous system activity, 
decrease renal sodium excretion, promote inflammation, and stimulate myocyte hypertrophy 
(Brashers, 2010). Furthermore, a protein produced by adipose tissue called adiponectin is found 
to be decreased in obesity and this reduction is associated with insulin resistance, a decrease in 
endothelial-derived nitric oxide (vasodilator), activation of the sympathetic nervous system and 
the RAAS (Brashers, 2010). Together these changes contribute to many of the complex 
mechanisms that are implicated in the development and sustainment of hypertension.  
  Other risk factors associated with primary hypertension include age as the lifetime risk 
of hypertension for normotensive adults between the ages of 55-65 is 90% (PHAC, 2010); family 
history as a first-degree family history of hypertension doubles the risk for the offspring; race, as 
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it is more common in black people; high sodium diet; excessive alcohol consumption; sedentary 
lifestyle; diabetes and dyslipidemia; personality traits and depression (Basile & Bloch, 2015). 
 Secondary Hypertension. Secondary hypertension is attributable to an identifiable cause, 
usually structural or hormonal in nature. It is imperative that those with secondary hypertension 
are identified and treated to prevent “adaptive cardiovascular changes” (Lee et al., 2011, p. 308), 
as well as treat the underlying condition associated with the hypertension. Some clues that the 
hypertension may be secondary include the development of hypertension before age 20 or after 
50 years of age, a higher severity of hypertension with an abrupt onset, other associated signs 
and symptoms, and lack of a family history of essential hypertension. Some common causes of 
secondary hypertension include sleep apnoea and medication use. For example, oral 
contraceptives may affect the RAAS and non-steroidal anti-inflammatory drugs may affect renal 
reabsorption of sodium and water (Basile & Bloch, 2015; Lee et al., 2011). Renal causes of 
hypertension include renal parenchymal disease, whereby damage to the nephrons inhibits 
normal filtration and renal artery stenosis through mechanisms of atherosclerosis (most common 
in older males) or fibromuscular dysplasia (characteristic in young women).  Other structural 
causes include coarctation of the aorta, causing reduced blood flow to kidneys, and changes to 
the baroreceptor response in the aortic arch. Finally endocrine causes of secondary hypertension 
include pheochromocytomas (catecholamine-secreting tumors), adrenocortical hormone excess 
(tumor or Cushing Syndrome), and thyroid hormone abnormalities (Basile & Bloch, 2015; Lee et 
al., 2011). 
Outcomes 
 Although hypertension may result in a diverse range of symptoms, including headaches, 
epistaxis, dizziness, flushing, sweating, and blurred vision, it can also be asymptomatic. 
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Unfortunately depending on the chronicity and degree of hypertension, damage to organs, 
notably the cardiovascular system, cerebrovascular system, the kidney, and retina may be 
occurring insidiously (Hammer & McPhee, 2014). Overall, hypertension can be associated with 
serious organ dysfunction, morbidity, and mortality and to understand this further, a brief 
overview of the physiological manifestations of hypertension will be presented in the following 
section.  
 Heart. Hypertension affects the heart by increasing the afterload against which the heart 
must contract. Like other muscles of the body, this increased workload results in cardiac muscle 
growth, however this growth, termed left ventricular hypertrophy, negatively affects functioning 
(Lee et al., 2011). Left ventricular hypertrophy causes a stiffening of the chamber, which 
increases the left ventricular filling pressure during diastole. This can result in pulmonary 
congestion and may progress to systolic dysfunction. These cardiac changes can lead to greater 
physiological dysfunction and left ventricular hypertrophy is a strong indicator of cardiac 
morbidity, correlating with development of congestive heart failure, angina, arrhythmias, 
myocardial infarction, and sudden cardiac death (Lee et al., 2011).  
 Blood Vessels. Damages to the blood vessels themselves due to chronic high pressures 
cause smooth muscle hypertrophy, endothelial cell dysfunction, and loss of elasticity (Lee et al., 
2011). Hypertension also hastens atherosclerosis in the vessels, likely through local injury and 
the loss of protective functions such as endothelial secretion of nitric oxide. In humans, nitric 
oxide is well accepted as a vasodilator with anti-inflammatory effects that prevent platelet 
adhesion and aggregation and provides protection against atherosclerosis (Brandes, 2014; 
Hermann, Flammer & Luscher, 2006). In their 1995 study, Huang et al., focused on the 
relationship between nitric oxide and hypertension by disrupting the gene responsible for 
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endothelial nitric oxide synthase in mice; they subsequently found that halting the production of 
nitric oxide led to hypertension in the subjects. Whilst it is more complex than a simple causal 
relationship between nitric oxide and the development of hypertension, the increased 
susceptibility to vessel damage and atherosclerosis increases the risk for aneurysms in the 
cerebrovascular system and aorta as do the risk of thrombotic events such as myocardial 
infarction and atherothrombotic strokes from emboli or direct occlusion of local vessels (Lee et 
al., 2011).  
 Kidneys and Retinas. In the kidneys, nephrosclerosis can result from damage to the 
local vasculature. Specifically, hyaline arteriosclerosis and fibrinoid necrosis of capillary walls 
can occur resulting in ischemic atrophy of tubules and glomeruli (Lee et al., .2011).  
Hypertensive retinopathy is a term describing a number of clinically visible signs on fundoscopic 
examination of the eyes, such as arterial venous nicking and arterial sclerosis, and although it 
may be asymptomatic these changes are indicative of chronic hypertension (Lee et al., 2011).  
 Overall, hypertension is linked to global physiological changes, which in turn can give 
rise to significant morbidity involving multiple organ systems and mortality. The effects on the 
body described above illustrate the necessity of aggressive management of hypertension and the 
associated risk factors and co-morbid conditions for the benefits on individual wellness, the 
healthcare system and society.  
Treatment 
 In many instances, hypertension may require treatment with antihypertensive medications. 
According to the CHEP guidelines (Daskalopoulou et al., 2015), average diastolic blood 
pressures of equal to or greater than 100 mmHg or average systolic blood pressures of equal to or 
greater than 160 mmHg without macrovascular target organ damage or other cardiovascular risk 
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factors requires treatment. In the presence of macrovascular target organ damage, the cut-off 
numbers recommended for treatment are lower at 90 mmHg diastolic and 140 mmHg systolic 
respectively. In the recent large randomized SPRINT trial, sponsored by the National Heart, 
Lung, and Blood Institute (The SPRINT Research Group, 2015), authors have found that 
intensive control of systolic blood pressure reduced rates of cardiovascular events by almost one 
third and mortality by almost one quarter. First line monotherapy without specific indications 
includes the thiazide diuretics, long-acting calcium channel blockers, angiotensin-converting 
enzyme inhibitors or angiotensin II receptor blockers (B.C. Guidelines, 2015). 
 Despite four million antihypertensive medication prescriptions being written every month 
(PHAC, 2010), the proportion of controlled disease is only 68.1 percent (Padwal, Bienek, 
McAlister & Campbell, 2016). Although this represents one of the suspected highest global rates, 
it still leaves room for improved treatment and effective prevention. Pharmacological therapy is 
important but represents one factor in the treatment of hypertension. Medication non-adherence 
is a significant phenomenon contributing to treatment failure in hypertensive patients. A 
longitudinal database study by Vrijens, Vincze, Kristanto, Urquhart and Burnier (2008) report 
that about one half of patients prescribed an antihypertensive drug stopped taking it within a year 
and on any given day about 10% of scheduled doses are omitted, further illustrating the necessity 
of risk factor modification in reducing the morbidity and comorbidities associated with 
hypertension.  
 The most current recommendations from the B.C. Guidelines (2015) are to treat 
hypertension according to cardiovascular disease risk factors and not solely to blood pressure 
targets. Treatment should include assessment and modification of risk factors related to 
hypertension and for those patients with borderline normal/high blood pressure, lifestyle 
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modification may be all that is required to bring their blood pressure into a normal range (B.C. 
Guidelines, 2015).  The following section will explore evidence-based lifestyle changes 
associated with hypertension treatment, followed by a discussion of MI.  
Lifestyle Modification 
 According to the CHEP guidelines (Daskalopoulou et al., 2015), health behaviour 
management should form the foundation of a treatment regimen to prevent or treat hypertension 
including exercise, dietary modification, weight reduction, alcohol consumption, sodium intake, 
and stress management. According to B.C. Guidelines (2015), 30-40 minutes of physical activity 
four to seven days per week can lower systolic blood pressure readings by 3.1 mmHg and 
diastolic blood pressure by 1.8 mmHg. Exercise should be of moderate intensity and include 
activities such as walking, jogging, cycling or swimming.  In a small randomized controlled 
study by Higashi et al., (1999), the effects of long-term aerobic exercise on endothelial function 
showed a favourable response associated with increased release of nitric oxide on vessel 
relaxation.  
 Dietary recommendations include eating a diet low in processed foods and high in 
nutrients. One eating plan consistently recommended in the literature is the “Dietary Approaches 
to Stop Hypertension” or DASH eating plan, which emphasizes fruits, vegetables, whole grains, 
poultry, fish, and nuts with low amounts of fats, red meats, sweets, and sugared beverages 
(National Institutes of Health, 2015).  B.C. Guidelines (2015) attributes following the DASH diet 
to a possible 11.4 mmHg reduction in systolic blood pressure and a 5.5 mmHg reduction in 
diastolic blood pressure. Furthermore, lowering sodium to less than two grams per day can help 
lower systolic blood pressure by 5.4 mmHg and diastolic blood pressure by 2.8 mmHg. Often a 
further benefit of exercise and diet is weight loss, which is also a behavioural modification 
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identified by the B.C. Guidelines (2015) that can lower systolic blood pressure by up to 6 mmHg 
and diastolic blood pressure by 4.8 mmHg. A healthy body mass index is considered 18.5 kg/m2 
to 24.9 kg/m2 with a waist circumference of less than 102 centimetres for men and 88 
centimetres for woman.  
 Finally, minimizing alcohol consumption in heavy drinkers to less than or equal to two 
drinks per day may reduce both systolic and diastolic blood pressure by 3.4 mmHg. Relaxation 
therapy may also lower systolic blood pressure by 3.7 mmHg and diastolic blood pressure by 3.5 
mmHg (B.C. Guidelines, 2015).  
 As stated, health behaviour management or lifestyle interventions are routinely 
recommended as first-line therapy in reducing hypertension and its adverse effects on the body. 
The CHEP guidelines (Daskalopoulou et al., 2015) discuss physical exercise, weight reduction, 
alcohol consumption, dietary changes, sodium intake, and stress management as lifestyle 
modification targets in hypertensive patients and the 2014 Joint National Committee guidelines 
(James et al., 2014) in the United States endorse the potential benefits of healthy diet, weight 
control, and regular exercise in blood pressure control. However, these guidelines do not address 
mechanisms to encourage these lifestyle changes in the clinical setting. Approaching lifestyle 
modification through the traditional methods of persuasion, advice-giving, scare tactics, and 
“expert power” do not encompass the values inherent in nursing and furthermore have not been 
shown to be effective in promoting change (Elder, Ayala & Harris, 1999; Hall, Gibbie & 
Lubman, 2012; Ren, Yang, Browning, Thomas & Liu, 2014).  As such, more effective strategies 
to address lifestyle modification are urgently needed in the primary care setting. One such 
strategy of burgeoning interest is MI, which accordingly will be discussed in the following 
section.  
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Motivational Interviewing 
 Described in 1983 by William R. Miller and originally utilized in alcohol addiction, MI is 
based on partnership, empathy and support, and addresses ambivalence to change by having the 
client voice their motivations for change and in turn listen to the counsellor reflect these 
motivations back to them (Hettema, Steele & Miller, 2005). As opposed to a set of skills, MI 
requires a way of being that encompasses the fundamental approach of collaboration, evocation, 
and autonomy within the interaction (Miller & Rollnick, 2002). Collaboration promotes 
partnership and an environment conducive to change as opposed to hierarchy and coerciveness. 
Evocation pertains to the interviewer provoking intrinsic motivation for change by drawing on 
the patient’s own perceptions, goals, and values. This contrasts sharply with the interviewer 
providing advice or insight often utilized in counselling. Autonomy respects self-determination 
and the patient’s desire to engage in the discussion regarding the behaviour in question. As 
Miller and Rollnick (2002) state, “when MI is done properly, it is the client rather than the 
counsellor who presents the arguments for change” (p. 34).  
 Although some authors have discussed MI as a brief intervention ideal for the clinical 
setting, it is not a set of techniques that can be employed quickly and without investing time into 
mastering the skill. Miller and Rollnick (2002) recognize that within the clinical healthcare 
setting, practitioners often desire a simpler technique useful in addressing patient reluctance to 
lifestyle change relevant to their health challenge. Some of the barriers that they identify in 
utilizing MI in the clinical setting include the time requirement of the intervention, the need for 
repeat sessions, and the lack of training in healthcare providers who often have no counselling 
background. In addressing this, Miller and Rollink describe adaptations of MI, such as brief 
advice and behaviour change counselling, that can be realistically applied in practice without 
mastering the overall method of MI.  
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 According to Miller and Rollnick (2002), brief advice is an opportunistic encounter 
commonly used within the healthcare setting whereby a patient presents with a problem and the 
practitioner recommends a lifestyle change. The patient may not be directly seeking advice but 
the healthcare advice may be helpful. An example of brief advice in the context of hypertension 
is a patient coming in for a medication refill for an antihypertensive medication and the 
practitioner recommending that the patient reduce their dietary sodium. Whilst there is a role for 
brief advice in the healthcare setting, particularly in regards to time management, it tends to be 
practitioner-led and doesn’t explore the patient’s motivation, values and/or ambiguity related to 
lifestyle change. However, with a small shift of emphasis placed on respectful interactions and 
eliciting permission prior to offering information, the spirit of MI can be elicited even in this 
brief exchange. 
 Behaviour change counselling is another adaptation of MI described by Miller and 
Rollink (2002).  This is an egalitarian, collaborative approach that may encompass advice giving 
within the process but is patient-centered and incorporates therapeutic skills, such as the use of 
open questions and reflective listening, in order to explore the patient’s point of view. Behaviour 
change counselling is similar to MI with regards to the use of open questions and reflective 
listening; however, they differ in regards to the overall goal of the session. MI requires the 
practitioner to effectively utilize specific psychotherapeutic methods to “diminish resistance, 
resolve ambivalence, develop discrepancy, and trigger behaviour change” (p. 279); whereas the 
focus of behavioural change counselling is to understand the person’s readiness to change and 
negotiate an agenda based on this.  
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Primary Healthcare and Nurse Practitioner Role 
  The above discussion on MI and adaptations of MI illustrate the potential utility of this 
behavioural counselling therapy within the context of hypertension treatment in the primary care 
setting. Approaching the treatment of essential hypertension with MI geared towards modifiable 
risk factors fits within a primary healthcare philosophy of respect for client autonomy. 
Furthermore, the impact of an aging population on the current healthcare system necessitates 
innovative change to meet the increased capacity (Romanow, 2002). Part of this transformation 
includes a shift to self-management of health conditions whereby nurse practitioners (NP) bring 
distinctive value in primary care, supporting people to live their best lives in health and illness 
(Pogue, 2007). 
 The family NP is in an ideal position to enrich chronic disease management across all 
populations because of on-average longer office visit times (Donald et al., 2010), and the focus 
of health promotion, preventative care, and management of chronic health conditions acquired 
from the nursing curriculum. Health promotion is foundational to the NP’s practice; therefore, 
addressing hypertension beyond pharmacological treatment will help to lessen the burden of 
chronic illness on individual health and the healthcare system and meet our commitment to  
“focus on promoting, improving and restoring health” (College of Registered Nurses of British 
Columbia, 2011, p. 14).  
 As highlighted, the significance of hypertension on time and financial expenditures in 
relation to the healthcare system cannot be overemphasized. Furthermore, although it may not be 
given the necessary attention due to its widespread incidence and subtle presentation, 
hypertension contributes significant morbidity and mortality to the adult population throughout 
the world. The pathophysiology of essential hypertension is such that the cause appears to be 
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complex and multifactorial involving interplay between environment and genetics. Lifestyle 
modifications, such as weight loss, dietary changes, and physical activity are consistently woven 
into current recommendations regarding treatment. However, how to approach these lifestyle 
modifications with patients in the clinical setting is an important area of inquiry. Therefore, the 
aim of this integrative literature review is to answer the question, “Is MI within a primary care 
context an effective method in eliciting change relating to modifiable risk factors associated with 
hypertension?” MI is the focus of this review because it is a flourishing strategy being researched 
in many different areas of care and it has the potential to integrate seamlessly within the holistic, 
client-centered approach of NPs practicing in primary care settings. 
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Chapter 3: Methodology 
 The purpose of an integrative review of the literature is to answer a targeted clinical 
question by systematically identifying and then synthesizing available research on the topic in 
question (Crawford, 2012). Undertaking an integrative review requires assembling the literature 
related to a topic, including quantitative and qualitative evidence, and then comparing and 
contrasting the research in order to provide a synopsis of the knowledge base and identify any 
gaps in the knowledge (Davies & Logan, 2008; Whittemore & Knafl, 2005). The primary 
objective is to identify gaps in the literature and to provide recommendations for clinical practice 
and/or the need for more research. An integrated review was undertaken to respond to the 
question: Is MI within a primary care context an effective method in eliciting change relating to 
modifiable risk factors associated with hypertension? The following section will provide an 
overview of this process.  
Integrative Review Process 
 The review process followed a step-wise approach with 1) the development of the 
research question 2) a preliminary search of the literature 3) a focused search with the 
development of inclusion and exclusion criteria and 4) analysis and reporting. An overview of 
each stage will be presented in the following sections. 
Development of the Research Question 
 In order to develop the research question, the PIE acronym (population, intervention, 
evaluation) was utilized as a framework to guide the process of clinical inquiry (Davies & Logan, 
2008).  
	 21	
Search terms were extracted from the question with the addition of broader terms in order to 
ensure a wide search strategy. For example, although hypertension is the diagnosis of concern, 
the search strategy paired “hypertension” with “cardiovascular disease” as search terms.  The 
search term “MI” was also paired with “counselling” and “cognitive behaviour” in order to 
uncover studies that may have used techniques consistent with the spirit of MI. The following 
sections will further discuss search terms, databases and eligibility criteria.  
Preliminary Search 
 While completing the preparatory work, prior to formally undertaking the integrative 
review, local, national and global guidelines related to hypertension were sought and reviewed in 
order to assess the literature for current recommendations regarding lifestyle modification and 
hypertension. Specifically, The Canadian Hypertension Education Panel guidelines 
(Daskalopoulou et al., 2015), B.C. Guidelines (2015), the World Health Organization 
hypertension guidelines (2013), Heart and Stroke Foundation (2016) and Canadian Hypertension 
Association (2016) websites were reviewed. This type of literature is a consensus of research that 
has been studied and processed in order to facilitate best practice guidelines based on current 
evidence. These literature recommendations provided a basis for the feasibility of the research 
question examining the non-pharmacologic treatment of hypertension. A preliminary search of 
MI was also undertaken using Google Scholar in order to increase background knowledge of the 
technique and to identify other potential search terms to facilitate a comprehensive search.  
Population: People With Hypertension 
Intervention: MI 
Evaluation: Risk Factor Modification 
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In May of 2016, a search of the University of Northern British Columbia’s library 
database was compiled. CINAHL, Medline OVID, PUBMED, and COCHRANE Reviews were 
accessed and searched using combinations of the following terms: Hypertension OR 
cardiovascular disease AND MI OR Cognitive therapy OR counselling AND cardiovascular risk 
factors AND primary healthcare. Appendix one is a table of the search strategy indicating the 
number of articles found per database as well as the search terms and BOOLEAN operators used. 
Table one is a schematic of the search strategy combining databases and total search results with 
subsequent numbers of relevant articles included once duplicates were removed and 
inclusion/exclusion criteria were applied.   
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Focused Search 
 After the preliminary search was conducted a focused search was performed with the 
intent of eliminating articles not applicable to the integrative review. This was undertaken by 
screening title and abstract data using specific inclusion and exclusion criteria. 
 Inclusion Criteria. During the title and abstract search, eligibility was assessed based on 
an article’s relevance to the research question. To be included, articles were to be focused on an 
adult population with MI or adaptation of MI as the main intervention and primary hypertension 
or unspecified cardiovascular risk factors as the main focus. The measurement of blood pressure 
as a primary or secondary outcome must have been included and the studies must be applicable 
to the primary care setting. Original peer-reviewed research was included with no limits on dates 
set due to the small volume of articles found.  
 Exclusion Criteria. Articles were excluded if they were not published in English and not 
available as full text from the University of British Columbia’s online database. Further, articles 
that did not specify the use of MI, or otherwise adequately describe the philosophy as being 
consistent with the spirit of MI as discussed in the background section of this paper, were also 
excluded to preserve the integrity of the review. Likewise, articles that focused on another 
discipline (such as pharmacy), inpatient care, or other chronic illness (such as addictions, heart 
failure, or diabetes) were not eligible for inclusion. Finally, articles were excluded if blood 
pressure readings were not a measured outcome. After this first stage of elimination was 
completed, and duplicate articles were removed, 39 full-text articles remained. These articles 
were then assessed for eligibility. Studies that were highly relevant to the review question were 
identified and a hand search of reference lists were undertaken to ensure the thoroughness and 
rigor of the search. A final count of eight articles was selected to be included in this review.  
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Analysis and Reporting 
 A total of eight articles met the criteria for the purposes of answering the topic in 
question. Using the Critical Appraisal Skills Programme (CASP) tools (CASP UK, 2013), each 
article was assessed separately with the tool appropriate for it’s design, methodological strengths, 
and outcomes. The CASP tools provide a framework from which to assess the quality of research 
and determine strengths and limitations of each study. Analysis from each article was then 
organized into a literature matrix in order to identify current themes related to the topic in 
question. Headings included in the literature matrix are as follows: research aim, study design & 
population, intervention/interventionist, measured outcomes, key findings, strengths/limitations, 
and miscellaneous. After a critical appraisal of each study was conducted and reviewed, four 
overall themes integrating the research emerged. These themes are as follows: support staff as 
interventionists; MI and treatment adherence; dose dependent effects of MI and physician 
adherence versus patient adherence. As such, the following section will report on these findings 
within the context of the above themes. 
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Chapter 4: Findings 
 The primary goal of this literature review is to examine the research regarding the 
effectiveness of using MI in the primary care setting to promote lifestyle change in hypertensive 
individuals. As such, a literature review was undertaken and as described in the previous section, 
eight research articles were selected and analyzed for quality and findings related to the above 
inquiry. The following discussion will examine and deconstruct the articles within the context of 
the emergent themes: clinic-based interventions; MI and medication adherence; dose dependent 
MI and hypertension; and physician adherence versus patient adherence. These will now be 
presented. 
Clinic-Based Interventions 
  Clinic-based interventions using medical office assistants (MOAs) and Registered 
Nurses (RNs) was an unexpected theme that emerged from the analysis of the literature. Three 
articles were appraised that focused on the engagement of support staff as being a feasible 
mechanism to deliver MI in primary care. Support staff, for the purpose of this review, refers to 
office staff with varying degrees of autonomy and responsibility, such as MOAs and RNs, whom 
are employed in a primary care setting but are generally not the primary care provider. These 
three articles will be now be discussed.  
 The first article by Willard-Grace et al., (2015) describes a randomized controlled trial 
designed to test the effectiveness of using clinic-based MOAs trained in behavioural counselling 
in hypertensive patients. This study encompassed a 12 -month study of health coaching to 
hypertensive participants randomized to the intervention arm of the trial. The MOAs were each 
given 40 hours of training over six weeks with a curriculum designed by the study team; and 
although the authors do not use the term MI to describe the counselling approach; the curriculum 
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as described in the protocol for this study (Willard-Grace et al., 2013) is consistent with the 
philosophical underpinnings and processes of MI, specifically with regards to being patient-
centered, eliciting patient knowledge and motivation, and exploring ambivalence within the 
counselling sessions.  
 The intervention consisted of the MOAs meeting with the patients prior to each office 
visit with their primary care provider. This pre-visit consisted of medication reconciliation, 
whereby reviewing patient knowledge and compliance and identifying barriers to medication 
adherence were discussed; agenda-setting, whereby the patient identified issues and priorities 
and the MOA shared (with permission) the issues of concern relevant to the patient; and lastly, 
laboratory results were reviewed with the patient. The MOAs then attended the office visit with 
the patient, where their role was to take notes, advocate for the patient, help prompt patients to 
remember questions or concerns, or alert the clinician to issues identified during the pre-visit. 
Finally, the MOA and the patient had a “post-visit” whereby the action plan was discussed and 
summarized. The MOAs were also required to check in with patients monthly and meet in person 
at least once every three months.  
 The study sample size was based on power calculations for the primary outcome and 
included 441 participants (mean age 52.7, SD 11.1, male n = 197) enrolled from two primary 
care clinics that serve San Francisco’s low-income population. Randomization was undertaken 
by random binary sequence, stratified by diabetes diagnosis but not by site, whereby patients 
opened sequentially numbered envelopes after research assistants conducted a verbal interview 
and took updated clinical measures. Descriptive and inferential statistics were used to analyze the 
data with comparisons between groups, including t tests and Chi tests for continuous and 
categorical data with a p-value equal to 0.05 and a 95% confidence interval.  
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 The primary outcome studied in this research was a composite of the proportion of 
patients who met at least one of the following targets for control for which the patient was 
uncontrolled at baseline: HbA1c of less than eight percent, a systolic blood pressure less than 
140 mmHg if non-diabetic or less than 130 mmHg if diabetic, and predetermined cholesterol 
targets. Composite goals can be difficult to interpret but in this case all three outcomes could be 
deemed comparable and logically grouped. Secondary outcomes include the proportion of 
participants in each arm meeting the above goals for all uncontrolled conditions at baseline, the 
proportion meeting each of the individual goals, and finally the mean change in measured values. 
The analysis of the data revealed that the participants receiving the intervention were more likely 
to meet the primary composite measure of one of the clinical goals (46.4% vs. 25.4%, p = 0.04) 
and secondary composite measure of reaching all clinical goals (34% vs. 24.7%, p = 0.05) but in 
reviewing blood pressure as an individual goal, there was no significant change to readings.  
 Strengths of this study include the attention given to the fidelity of the MOA’s training as 
discussed in the study protocol, although it is important to note the authors express concern 
regarding the quality of the intervention specific to one of the MOAs who was absent for eight 
weeks during the study and had reported difficulty establishing trusting relationships. One 
limitation of this study is that the researchers were not blinded to the patient assignment at the 
12-month follow-up. However, the authors address this and state that there is low likelihood for 
bias due to the objective nature of the measurements. Another limitation of this study is that the 
population was largely Latino and African American people with low-incomes, which is 
important to consider when applying findings as it may limit the generalizability.  
  The second article by Ma, Zhou, Zhou and Huang (2014), describes a randomized 
controlled trial involving twelve Registered Nurses delivering MI to Chinese patients with 
	 29	
essential hypertension taking at least one antihypertensive medication. The aim of the study was 
to test the effectiveness of MI counselling compared to usual care for these patients. The twelve 
nurses were responsible for five patients each and met with their assigned patients for 30-40 
minutes per session for eight sessions over six months. The nurses followed an MI-based 
counselling protocol and the patients were required to keep daily diaries recording information 
on medication adherence, dietary habits, physical activity, drinking and smoking, illness 
perception, physical, and mental health. Subsequent goals were developed based on the content 
of the diary during the counselling sessions.  
 The study included a convenience sample of 120 adult patients (mean age 58, SD 11. 68; 
male n = 59) with no significant baseline differences recruited from two community health 
centres in Guangzhou City, China. Randomization was achieved by having the eligible 
participants select a numbered envelope depicting which group the patient would be assigned to. 
The following clinical and laboratory outcomes were measured at baseline and post intervention: 
blood pressure, serum creatinine, cholesterol, and blood glucose; and treatment-adherence, 
quality of life, and self-efficacy were also measured at baseline and post intervention using the 
Treatment Adherence Questionnaire of Patients with Hypertension (TAQPH), the General Self-
Efficacy Scale (GSES), and the Medical Outcomes Study 36-item Short Form (SF-36). The 
authors report that these questionnaires have been validated in previous studies. Analysis of the 
data was performed using descriptive and inferential statistics with independent samples t-test to 
examine differences between groups and paired samples t-test to examine differences within 
groups.   
 The analysis of the study data identified that there were significant (p < 0.05) differences 
in adherence related to medication use, dietary habits, smoking and alcohol use and physical 
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activity between the intervention and control groups.  Additionally, there were significant 
decreases in systolic and diastolic blood pressure between the intervention and control group (p = 
0.011; p = 0.027), and a significant drop between the baseline versus the post-intervention BP 
values for the MI group. There were no statistical differences in laboratory indices (serum 
creatinine, total cholesterol, triglyceride, low density lipoprotein, high density lipoprotein, 
fasting blood-glucose, and postprandial blood-glucose) between the two groups and within the 
subjects in the groups. The General Self-Efficacy Scale (GSES) scores were higher in the MI 
group, but they did not reach statistical significance (p = 0.261). However, the total scores of the 
SF-36 scale were higher in the MI group and did reach statistical significance (p = 0.048). 
  Strengths of the study include the authors description of the philosophy of MI used in the 
study, the quality of the nurses training in delivering the intervention as well as how fidelity was 
ensured during the trial by having each interaction audiotaped and reviewed by a trainer, who 
then provided written feedback on the audiotaped consultations to help the nurses improve their 
counselling skills. Although participating nurses could not be blinded, outcome assessors were 
not part of the study thus limiting potential measurement bias. Having said that, the authors do 
note that the nurses performing the intervention were acquainted with the nurses performing the 
usual care, which could lead to potential bias. 
   Limitations of this study include relying on only one blood pressure reading per visit 
instead of the recommended averaging of two to three readings per visit that most studies 
describe, and the short length of the intervention as Registered Nurses met with their assigned 
patients for 30-40 minutes per session for eight sessions over six months. This study was also 
underpowered as it was calculated that 110 participants were needed with a projected 10% 
attrition rate for a total of 120 patients; however, 14 participants left the study resulting in a 
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sample size of 106. The authors did use an intention-to-treat analysis but state that the missing 
cases most likely have an effect on MI results. Finally, this study population is limited to Chinese 
participants, illustrating a lack of sample diversity, which will impact upon the generalizability 
of the study findings. 
 The third study by Woollard et al., (1995) describes a randomized controlled trial that 
assessed whether a lifestyle modification program delivered by Registered Nurses in a general 
practice setting would improve blood pressure control in treated hypertensive patients. There 
were three arms to this trial: a control group, a low intervention group and a high intervention 
group. Over 18 weeks, the low intervention group had a single face-to-face appointment and then 
five 15-minute telephone counselling sessions versus the high intervention group that had six 
face-to-face counselling sessions lasting 45 minutes each. Both intervention groups also received 
a written educational manual to help reinforce goals and behaviour modification strategies. MI 
was specified as the counselling strategy used but the authors fail to discuss the training that the 
nurses’ received or if there were any quality control interventions.  
 This Australian study had 166 participants (mean age 58, no SD reported, male n= 79) 
recruited from thirteen general practices with a wide socio-economic range, and the authors 
report no significant baseline differences. Sampling was by convenience and occurred with a 
practice audit of 13 general practices in the Perth metropolitan area identifying 566 treated 
hypertensive patients. These patients were sent a letter informing them of a practice BP 
programme and the first 219 patients available by telephone were invited to participate with 166 
agreeing to enter the trial. Details of how randomization was obtained are not given. Statistical 
analysis was both descriptive and inferential using Chi-squared analysis of variance, Duncan’s t-
tests for post-hoc comparisons and linear regression. P-value was set at < 0.05 with 95% 
	 32	
confidence intervals. Measured outcomes include weight, urine sodium, alcohol use, and blood 
pressure. Interestingly, findings show that alcohol use and sodium intake were significantly 
lowered in the low intervention group and weight and blood pressure were significantly reduced 
in the high intervention group (p<0.05; exact p values not given).   
 This study uses the same interventions of MI at different doses delivered by nurses in a 
primary care setting. Strengths of the study include utilizing objective measurement data, such as 
height, weight, and 24-hour urine sodium. As well, recorded blood pressures were the mean of 
three measurements taken at three-minute intervals after sitting quietly for 10 minutes, which is 
consistent with current guidelines. However, there are several important limitations to this study. 
For example, the authors do not disclose who performed the baseline and post-intervention 
outcome assessments and whether these people were blinded, which could indicate potential for 
bias. Furthermore, there was no mention of rate of follow-up with study participants or attrition. 
Finally, there was no consideration of the use or initiation of antihypertensive medications during 
the study period. 
 The above three trials have the common theme of utilizing clinic staff as the 
interventionists delivering MI within the primary care setting. The studies differ in that two of 
them utilize Registered Nurses to deliver the MI, which is a professional role typically well 
versed in patient care and autonomy. The remaining study utilizes MOAs, which are generally 
not patient care providers. The similarity amongst these studies is that the interventionists are not 
the primary care providers but are providing the intervention in the primary care setting.  
MI and Treatment Adherence 
 Many of the studies included in this review allowed patients to participate irrespective of 
whether taking antihypertensive medications. However, two studies examined the effects of MI 
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specifically on medication adherence.  One of these studies is a randomized controlled trial by 
Ogedegbe et al. (2008) that looked primarily at the effect of MI on medication adherence and 
blood pressure. The authors of this study specify that the intervention delivered was MI 
conducted by trained research assistants. They briefly discuss measurements to ensure fidelity of 
the intervention through audiotaping and reviewing by a trained reviewer. The intervention was 
delivered over 30-40 minutes at three, six, nine, and twelve months. The primary outcome was 
adherence measured with electronic pill monitors and the secondary outcome was blood pressure 
from baseline to twelve months. 
  This randomized controlled trial included 190 hypertensive adult African American 
people (mean age 54, SD 11.35, male n= 12%) recruited from two community-based primary 
care practices in New York City. Eligible participants had to be on antihypertensive medication, 
have uncontrolled hypertension on two successive office visits and be fluent in English. A 
statistician undertook randomization, using sealed envelopes, with separate randomization 
schedules developed from a computerized random-number generator to assure equal numbers in 
each group. Descriptive and inferential statistics were used and following intent-to-treat 
principles, mixed effects regression models were used because missing data occurred in 16% of 
patients due to damage to the medication event monitoring system (MEMS) pill caps.  
 Overall results of the study show a significant decrease in medication adherence for the 
control group receiving usual care (p = 0.006) and an overall non-significant increase in 
adherence for the intervention group with a between-group difference of 13%. The results of the 
intervention on blood pressure showed a significant overall drop in systolic blood pressure of 5.1 
mmHg between both groups and a further albeit non-significant drop in the intervention group of 
6.1 mmHg (p = .065). There was also a significant drop in diastolic blood pressure of 3.5 mmHg 
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(p = .01) overall, but no additional drop for the intervention group. In summary, the authors 
highlight that MI is a viable approach to increasing treatment adherence and improve outcomes 
in patients with hypertension. 
 Overall, strengths of the study include the twelve-month intervention interval and the use 
of the MEMS pill cap, which is considered a gold standard in objective medication adherence 
measurement. Furthermore, although research assistants and patients were not blinded, the 
outcome assessors were which is important in reducing the possibility of measurement bias. 
Limitations of this study include the limited generalizability because the population was 
predominantly low-income African American women. Furthermore, as discussed by the authors, 
the researchers did not have any mechanism in place to measure medication intensification, 
which is an important variable that could account for the lower systolic blood pressure. Finally, 
although the authors state that they didn’t control the mechanism for blood pressure 
measurement to keep it realistic, inconsistency in measurement practices could influence results.  
 Similarly, the study by Ma et al. (2014) previously discussed under the heading, “clinic-
based intervention” also examined treatment adherence as one aspect of their study. This was a 
randomized controlled trial with 120 participants. The intervention group received eight sessions 
of MI over six months by trained clinical nurses. However, with regards to medication adherence, 
instead of using an objective measurement such as the electronic medication cap, they used the 
Treatment Adherence Questionnaire of Patients with Hypertension (TAQPH) which the authors 
report has a content validity index of 0.93. This test uses a 4-point Likert-type scale and includes 
medication, diet, exercise, weight control, stimulation and relieving stress. Descriptive and 
inferential statistical analysis was done with independent t-tests and paired samples t-tests. 
Overall, the scores for medication adherence were significantly higher for the intervention group 
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versus the control group post-treatment with a p value of 0.039. There was also a significant 
increase in medication adherence from baseline to post-intervention within subjects of the 
intervention group.  However as previously discussed, this study has many limitations such as 
only relying on one blood pressure measurement instead of the recommended averaging of a few 
and being underpowered for sample-size. Furthermore, recall for medication adherence relied on 
patient diaries, which may be susceptible to recall bias and a desire to report pleasing outcomes 
to healthcare providers, compared to an objective measure such as the MEMs cap utilized in the 
study by Ogedegbe et al. (2008). 
 The above two studies measured medication adherence after an MI intervention. The first 
study by Ogedegbe et al. (2008) measures medication adherence as a primary outcome and uses 
an objective measurement tool. The second study by Ma et al. (2014) measures medication 
adherence as a secondary outcome using a validated questionnaire. Both studies findings show a 
favourable effect of MI on medication adherence and subsequent blood pressure readings. 
Dose Dependent Effects of MI 
 Another theme that emerged from the literature is dose dependent effects of MI on 
hypertension. Three randomized controlled trials examine if the “dose” of MI may affect the 
outcome. These three trials will each be discussed in the following section. 
 A randomized controlled trial published in 2013 by Hardcastle, Taylor, Bailey, Harley 
and Hagger using MI as the intervention had a number of aims, one of which was to determine 
the effect of counselling session attendance on maintenance outcomes. The study had two arms: 
an intervention group that received standard exercise and nutrition information plus up to five 
face-to-face counselling sessions versus a minimal intervention comparison group that received 
the standard information only.  In keeping with the philosophy of MI, the researchers did not 
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assign a number of sessions to be attended for the intervention group but instead offered four 
opportunities over six months after the initial session. The other aims of the study included 
assessing if changes in outcomes lasted in a one year follow up (primary aim), as well as 
examining effects of the intervention on outcomes for subgroups presenting with specific 
cardiovascular disease risk factors; namely, a body mass index of 28 kg/m2 or above, 
hypertension or hypercholesterolemia. The interventionists in this trial included a physical 
activity specialist and a dietician who received training in MI techniques during two, four-hour 
sessions with one of the authors. The interventionists also audiotaped three consultations during 
the first two weeks of the trial, which formed the basis for a dialogue between the trainer and 
health professional on difficulties encountered. The authors state that the practitioners were 
trained to a minimally acceptable standard prior to commencement of the trial based on the 
established MI intervention protocol. However, a complete analysis of fidelity measures was not 
carried out during the intervention due to limited resources.  
 The trial used a convenience sample of 334 primary care patients (mean age 50.22, SD 
0.58) recruited from a local primary care health centre database, whom were eligible if they had 
one of the cardiovascular risk factors as outlined above. The patients were randomized into the 
MI intervention and minimal intervention arms of the study by a statistician who developed a 
randomization protocol stratified by gender and age to ensure an even distribution of key 
demographic characteristics and to avoid groups that were unbalanced which may skew the 
analysis. There were no reported significant baseline differences in participants between the 
treatment and control groups, but when assessed for recruitment bias against those who declined 
participation, participants were found to be older with a mean age of 51, have a higher body 
mass index, and have lower systolic blood pressure and lower cholesterol levels. Outcome 
	 37	
measurements were performed at baseline, six months, and eighteen months and included: blood 
pressure, body mass index, fasting cholesterol, self-reported physical activity using the 
International Physical Activity Questionnaire, physical activity stage of change, and diet using 
the DINE scale to measure fat intake and the five-a-day community evaluation questionnaire. 
Statistical analysis was both descriptive and inferential with multiple steps undertaken. First the 
authors checked for bias in the samples arising from attrition with two one-way MANOVAs, 
followed by mixed model ANCOVAs for multiple comparisons in order to assess the effects of 
intervention on each of the variables separately followed by hierarchical linear multiple 
regression analyses to test for the effect of number of sessions attended on outcomes. 
 The analysis of the data for the primary aim of the trial showed significant increases in 
walking (p=0.032) and significant reductions in cholesterol (p = 0.015) that were maintained at 
12 months post intervention for the intervention group; although the authors state that the mean 
difference of cholesterol of -0.16 mmol/l between groups cannot be interpreted as clinically 
significant. In relation to whether the dose of MI would increase the intervention effect, there 
were no significant effects for the dose of MI with the exception of triglyceride levels and hence 
there was no significant effect for the subgroup of people with hypertension identified in this 
study.  
 Strengths of this study included the collection of data at twelve months post intervention 
to assess for sustained effect. The authors also provided a thorough explanation of the key 
elements of the MI intervention. Furthermore, outcome assessors were blinded thus reducing bias. 
Limitations to this study include a low level of participation as only 28% of people contacted 
accepted the invitation to participate and as mentioned there were significant differences in those 
that joined the study. Furthermore, there was a low rate of attendance of the counselling sessions 
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with a mean attendance of two sessions and although this may mimic reality, the authors do 
acknowledge that with more resources the intervention may have had greater attendance if 
offered more frequently.  
 Similar to Hardcastle et al. (2013), the study by Schoenthaler et al. (2015) examines the 
dose dependent response to MI. However, this study evaluates a single session of counselling 
(SSC) enhanced with printed educational material versus an intervention of ten weekly group 
classes (intensive phase) on therapeutic lifestyle changes (TLC) followed by three individual MI 
sessions (MINT-TLC). The primary aim of this study focused on reduction of blood pressure 
between the two groups at six months and the secondary aim tested whether the intervention 
would result in greater improvements in blood pressure control over the single counselling group. 
The intervention was carried out by health educators trained in behavioural counselling 
techniques and the authors give a thorough description of the extensive training and fidelity 
measures taken in their study protocol (Schoenthaler et al., 2011).  
 The study population was hypertensive African American people and included a 
convenience sample of 194 participants (mean age 57, SD 10.2, males n = 96) recruited from a 
primary care practice out of Bellevue Hospital Center in New York City. Adult participants were 
eligible if they self-identified as African American, were fluent in English, and had uncontrolled 
blood pressure irrespective of antihypertensive medications. Participants were randomized under 
their primary care physicians; therefore an algorithm that has yielded balanced groups for 
multiple studies was used. Outcomes were measured at baseline, three, and six months and 
included blood pressure, medication adherence using a validated scale, and intervention 
adherence using attendance sheets.  
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 The authors found that systolic and diastolic blood pressure declined significantly in both 
groups from baseline to six months with no significant differences between groups even with the 
addition of diabetes status and medication non-adherence as covariates. The net-adjusted 
reduction in systolic blood pressure by six months was 12.9 mmHg for the SSC group versus 9.5 
mmHg for the MINT-TLC group and the reduction in diastolic blood pressure was 7.6 mmHg for 
the SSC group versus 7.2 mmHg for the intervention group. With regards to the secondary 
outcome, there were no significant group differences in the proportion of patients with adequate 
blood pressure control at 6 months (p = 0.437). Finally, the dose response analysis showed no 
significant dose-response effect, although only one third of patients randomized to the 
intervention group were considered “completers,” which the authors define as attending eight or 
more sessions. 
 Limitations of this study include poor attendance levels specific to the MI arm of the trial, 
as only one third of participants attended eight or more group sessions and only 35% completed 
all three individual maintenance sessions with 32% not attending any session. In Contrast, 91% 
of patients randomized to the individual counselling session attended; however, the authors did 
show there was no significant dose-response effect upon analyses. Research assistants were not 
blinded to randomization assignment although the authors do state that there would be low 
potential for bias due to blood pressure readings taken on validated automated devices and 
hidden from research assistants and patients. There was also slight imbalance on baseline 
variables of diabetes and medication adherence between the two groups of participants, for 
example 38.5% of participants had diabetes in the SSC group versus 49.5% in the MINT-TLC 
group and 67.4% reporting medication non-adherence in the SSC group versus 79.6% in the 
MINT-TLC group. But as stated, these were calculated as covariates and sensitivity analyses 
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modeling these variables did not change overall findings. Finally, there was no usual care or 
“control” group although one could argue that an individual counselling session to a 
hypertensive individual should constitute usual care. 
 The third study by Miura et al. (2004) utilized a multicomponent program titled PACE 
(Patient-centered Assessment and Counselling for Exercise plus nutrition) adapted specifically 
towards the Japanese diet to test the effectiveness for treating patients with essential 
hypertension. The researchers recruited a convenience sample of 57 outpatients (mean age 62, 
SD 10, male n= 29) from the Department of Cardiology, Fukuoka University Hospital to one of 
three arms of the trial: 1) a PACE+ Japan follow-up group who were given an action plan sheet 
and also received systemic health counselling by a physician and counsellor every four weeks for 
24 weeks, 2) a PACE+ Japan only group who were given an action plan sheet but did not receive 
the counselling, and 3) an age- and sex-matched control group for comparison. This trial does 
not specify that MI was the counselling technique utilized but the description of the 
characteristics of the counselling were deemed to be similar, such as patients identifying the 
areas that need work and controlling which targets he or she would like to improve. There were 
no investigations into the effectiveness of the counselling intervention either from an expert or 
participant opinion. Outcomes measured at baseline and post intervention include: height, weight, 
percentage of body fat, blood pressure, urine sodium, urine potassium, urine creatinine, and daily 
physical activity with an accelerometer.  
 Statistical analysis was descriptive and inferential using analysis of variance and 
Scheffe’s multiple comparison test for continuous variables; Pearson correlation and Spearman 
correlation for correlations between variables; and multiple regression analysis for dependence 
on changes in systolic blood pressure on changes in other variables. P = 0.05 unless otherwise 
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indicated. The findings of this study show a significant drop in systolic blood pressure in the 
PACE + Japan follow-up group (-12+/-10 mmHg) versus the control group (-3+/-9 mmHg). 
There were no significant differences in diastolic blood pressure among the three groups (no p 
values given). There was also significant decreases in percentage of body fat, urine sodium and 
total energy intake and significant increases in total energy expenditure and exercise energy 
expenditure for the PACE + Japan follow-up group. Finally, changes in systolic blood pressure 
were positively correlated with changes in urine sodium in all patients (p = 0.011), leading the 
authors to state that their intervention may have been effective at reducing blood pressure by 
decreasing sodium intake in the PACE + Japan follow-up group. 
 Strengths of this study include the use of objective biophysical measurements as well as 
using an objective measure of physical activity. Limitations of this study include a small sample 
size of 57 participants as well as significant baseline differences in body mass index and 
percentage of body fat in the PACE + follow up group. Furthermore, the authors do not disclose 
how patients were recruited or how randomization was carried out, who the outcome assessors 
were or if blinding occurred, which highlights possible recruitment and/or measurement bias. 
Finally with the exclusion of p values, it was difficult to decipher results of the PACE+ Japan 
follow-up group compared to the PACE+ Japan only group, as these were not adequately 
discussed in the body of the paper. 
 In summary, the above three randomized controlled trials examined dose-dependent 
effects of MI on hypertension. The first study was unique in that five counselling sessions were 
offered and attendance was left open to the participants. The second study had a single session 
counselling group versus 10 weekly group classes followed by three individual MI sessions and 
the third study included 20 minutes of counselling at each hospital visit every 4 weeks for 24 
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weeks versus the low intervention group that received an action-plan sheet. Overall, MI had 
inconsistent dose-dependent effects on hypertension outcomes. 
Physician Adherence versus Patient Adherence 
 In the review of the literature, one study was identified that sought to test interventions to 
increase physician adherence to national guidelines and interventions to increase patient 
adherence to lifestyle recommendations both as separate and combined interventions (Svetkey et 
al., 2009). The authors designed a nested two-by-two, randomized controlled trial where eight 
primary care practices composed of 32 physicians (mean age 48, SD of 10, male n = 21) were 
randomized to physician intervention or usual care. Within these practices, 574 patients (mean 
age 60.5, SD 11.4, male n = 39%) were randomized to patient intervention or usual care.  
 The physician intervention was comprised of two online training modules, a laminated 
summary of national guidelines to use in practice, self-monitoring, and quarterly feedback 
reports. Participants in the patient intervention group attended 20 weekly group sessions over six 
months using MI techniques by two experienced behavioural interventionists who are trained and 
certified in the use of MI techniques. Two community health advisors further followed up the 
patients with monthly phone calls for one year to offer brief lifestyle counselling after the initial 
intervention. Patients in the usual care group received one individual visit with an interventionist 
to receive advice and written materials on lifestyle modification to control hypertension. 
 The primary outcome was a change in systolic blood pressure from baseline to six 
months and the secondary outcomes were a change in diastolic blood pressure at six months, 
blood pressure change at 18 months, effect of treatment on weight loss, dietary pattern, physical 
activity, fasting blood glucose and lipids, and the proportion of patients with adequate blood 
pressure control. It should be noted that the original primary outcome was the proportion of 
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patients with adequate blood pressure control; however, due to an unanticipated 60% of 
participants being at goal blood pressure at baseline it was changed.   
 The findings of the study show an overall change of 0.3 mmHg on systolic blood pressure 
for those patients randomized to the physician intervention group, which did not reach statistical 
significance (p = 0.72). There was a significant reduction on systolic blood pressure of 2.6 
mmHg for patients in the intervention group (p=0.01), which the authors attribute to dietary 
changes and weight loss based on significant improvements in these outcomes during the trial. 
The combined intervention group showed the greatest reduction of -9.7 +/- 12.7 mmHg (p=0.03) 
in systolic blood pressure illustrating that the interaction of the two interventions were the most 
effective. However, significant differences in blood pressure were not maintained at 18 months.  
 Strengths of this study include the nature of the combined intervention studying provider 
adherence to guidelines with an emphasis on lifestyle counselling and patient adherence to 
lifestyle modification. Limitations include physician self-reporting regarding lifestyle 
counselling which increases the risk of recall bias. Furthermore, patients that did not complete 
the study measurements were not included in analyses, although the authors note that the follow-
up rate was greater than 91% at six months and 88% at 18 months and sensitivity analyses 
assuming no change in blood pressure in those that didn’t complete demonstrated similar results.  
As mentioned, 60% of participants had controlled blood pressures at baseline, which highlights 
what the authors’ state as a relatively healthy cohort with limited comorbidity. This coupled with 
the fact that only ten percent of eligible participants were randomized highlights the possibility 
of recruitment bias and limited generalizability of the result. 
 This study was unique in that it looked at both provider and patient interventions with 
regards to improving blood pressure. The study looked at each intervention as a separate entity 
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and then combined the interventions for the most effective result on blood pressure and 
furthermore the most reflective of a collaborative partnership in primary care. 
Summary 
 A comprehensive review of the literature identified eight core articles that explored the 
use of MI for the management of risk factors relating to hypertension in the primary care setting. 
A critical appraisal of the articles was undertaken and a concise overview of the findings, in 
addition to the strengths and weakness of the evidence has been presented. As discussed in the 
methods section of this paper, these studies were chosen against a set of criteria as follows: adult 
population, MI or intervention with the “spirit” of MI, and blood pressure as an outcome. All of 
the studies have very unique features related to how MI is delivered, how many sessions of MI 
are used, ethnicity or socioeconomic status of population sample, and primary and secondary 
outcomes. However, four themes enabling these studies into groupings emerged upon review of 
the literature: clinic-based intervention; MI and treatment adherence; dose dependent effects of 
MI; physician adherence versus patient adherence. Hence the eight studies are presented and 
critically reviewed above with the context of these four themes. The following section will 
discuss these findings and will continue to identify recommendations for practice, research and 
education. 
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Chapter 5: Discussion and Conclusion 
 Hypertension places a burden both on the individual, with its potential for increased 
morbidity and mortality, and the healthcare system, with its heavy toll on human and economic 
resources (WHO, 2013). Hypertension accounts for over 20 million visits to primary care offices 
in Canada each year and consumes a vast amount of healthcare dollars (PHAC, 2010). Globally, 
hypertension is considered a major public health issue, as complications of hypertension account 
for 9.4 million deaths worldwide every year (WHO, 2013). Whilst the etiology of primary 
hypertension is considered multifactorial, it can partly be viewed within the context of lifestyle 
choices. Global rates of hypertension are rising and the WHO (2013) attributes this increase to 
population growth, aging and the presence of behavioural risk factors, notably unhealthy diet, 
harmful use of alcohol, lack of physical activity, excess weight, and exposure to persistent stress. 
Contemporary guidelines support health behaviour management as a key component in 
effectively treating hypertension (Daskalopoulou et al., 2015; James et al., 2014; WHO, 2013). 
However, clear guidelines on best practice related to how health behaviour management should 
be approached in primary care practice are lacking. MI has been identified as a potential 
mechanism to promote self-management and health lifestyle practices that can prevent and 
manage hypertension in the community context (Ma et al., 2014).   
 MI, originally developed for the field of addiction medicine, is being utilized in other 
areas of medicine such as asthma, diabetes, physical activity, weight loss, treatment adherence 
and follow-up. MI, based on collaboration, is a person-centered, non-authoritarian counselling 
style designed to strengthen a person’s motivation for change towards a clearly identified goal 
(Hall, Gibbie & Lubman, 2012). Working in primary care involves collaborative delivery of 
healthcare with the forefront goals of health promotion and disease prevention. 
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 Techniques that engage patients as partners in their healthcare and support the 
development of effective self-management are known to give rise to improved outcomes (Linden, 
Butterworth & Prochaska, 2010). MI is an evidence-based tool that is realistic for primary care 
practitioners to incorporate into the counselling component of their practice. Because primary 
hypertension is responsive to lifestyle modification, it is well within the NP role as primary care 
providers to utilize a behavioural change method such as MI in practice. It is this line of inquiry 
that led me to explore the research question: Is MI within a primary care context an effective 
method in eliciting change relating to modifiable risk factors associated with hypertension? 
 In a comprehensive search and review of the literature, MI was found to be a promising 
clinic-based model for the management of primary hypertension. Eight studies were identified 
and reviewed. Following a critical appraisal of the literature findings, five of the eight studies 
captured in the review highlight significant decreases in blood pressure related to the MI 
intervention (Ma et al., 2014; Ogedegbe et al., 2008; Schoenthaler et al., 2015; Svetkey et al., 
2009; Woollard et al., 1995) and one study illustrated a non-significant decrease in systolic blood 
pressure (Miura et al., 2004). The remaining two studies showed no effect on blood pressure but 
did illustrate other efficacious effects on cholesterol, exercise capacity specifically minutes of 
walking per week and HbA1c levels (Hardcastle et al., 2013; Willard-Grace et al., 2015). The 
following section will discuss implications of these findings related to clinical practice, 
education and research.  
Implications for Clinical Practice, Education, and Research 
 Outcomes gathered from the analysis of the literature serve to highlight recommendations 
to promote the transition from theory to clinical practice, inform educational guidelines, as well 
as highlight areas for further relevant research.  
	 47	
 Discussion and Implications for Clinical Practice. The following section will discuss 
the key findings of this review and their implications for clinical practice. These will be 
discussed in relation to the four themes generated from the analysis of the literature: clinic-based 
interventions; MI and treatment adherence; dose dependent effects of MI; and physician 
adherence versus patient adherence.  
 Clinic-based interventions. The studies analyzed as part of this review incorporated MI 
interventions that varied in duration and format. For example, the time range of the MI 
intervention varied from 15-45 minutes and included interventions offered in person to those 
delivered remotely by telephone. In the real world setting, a primary care practitioner may have 
approximately ten minutes to address a behavioural change issue with a patient (Emmons & 
Rollnick, 2001); and Emmons and Rollnick (2001) acknowledge that even simplified adaptations 
of MI in the clinical setting will likely take longer than the traditional advice-giving approach, 
representing a potential limitation when delivering MI in this setting (Miura et al., 2004). 
Furthermore, the findings of the captured studies documented varied delivery processes. For 
instance, some were delivered by trained RNs (Ma et al., 2014; Woollard et al., 1995;), while 
others were delivered by trained research assistants (Ogedegbe et al., 2008) or health educators 
(Schoenthaler et al., 2015)). Despite this variation in approach, MI interventions had largely 
successful outcomes on blood pressure readings and could be included in clinical practice using 
an interdisciplinary approach. For instance, clinic-based interventions utilizing a collaborative 
interprofessional team approach, such as RNs and physicians, to co-deliver MI may be one way 
to overcome the time constraints in the primary care setting. Furthermore, a collaborative care 
model has the conceivable benefit of improving access, efficiency, and quality of care whilst 
“empowering patients to enhance their role in prevention and self-care” (Canadian Medical 
	 48	
Association, 2007, p. 5). Further, while the two studies utilizing RNs to deliver the MI showed a 
positive effect on blood pressure (Ma et al., 2008; Woollard et al., 1995), the study utilizing 
MOAs showed no effect on blood pressure (Willard-Grace et al., 2015). It is difficult to 
speculate the underlying reason for these different results, as the three studies reviewed are 
diverse in their delivery of MI regarding dose, intervention length, and follow-up.  
 In reviewing the global literature on MI, one large systematic review and meta-analysis 
of 72 randomized controlled trials using MI with various lifestyle problems and diseases (Rubak, 
Sandboek, Lauritzen & Christensen, 2005) states that psychologists and physicians obtained an 
effect in approximately 80% of the studies reviewed, while other healthcare providers (nurses, 
midwifes, dieticians, other healthcare providers) obtained an effect in 46% of the studies. 
However, similar to this review which identified the diverse nature of interventions and study 
processes, the authors acknowledge that some of this discrepancy is most likely due to the design 
of the studies relating to the frequency of encounters, intervention dosage, and short follow up 
periods. The authors further emphasize that effects of MI are likely related to duration and 
number of client-counsellor encounters, training and experience of MI methods, and client-
counsellor relationships. If this is the case, the family NP would be in an ideal position to 
incorporate a behavioural counselling strategy such as MI into practice, given the NP’s holistic 
focus on health promotion and prevention, longitudinal relationships in the family practice 
setting, and longer than average consultation times (College of Registered Nurses of Nova Scotia, 
2016; Horrocks, Anderson & Salisbury, 2002). For example, studies have demonstrated high 
patient satisfaction associated with the NP role and practices (Stanik-Hutt et al., 2013).  One 
Canadian study focused on chronic disease management among four different models of primary 
health care delivery in Ontario (Russell et al., 2009). The authors state that one of the key 
	 49	
findings across the whole sample was “high-quality chronic care delivery was more likely with 
the presence of a nurse-practitioner” (p. 315). These positive client-provider relationships may 
further support the success of MI interventions for those with primary hypertension and other 
chronic diseases. As such, NPs should harness their capacity when working with patients with 
chronic health challenges thus helping to cement the NP’s unique contribution and value within 
the health care system.  
 MI and Treatment Adherence. Treatment adherence, particularly regarding medications, 
is a well-documented problem in the management of chronic diseases (Daskalopoulou et al., 
2015). Medications often play an integral role in hypertension treatment with many patients 
requiring combination therapy of one or more pharmaceutical agents (WHO, 2003). As discussed 
in the background section of this paper, it is known that approximately 10% of antihypertensive 
doses are omitted daily (Vrijens et al., 2008) and Alhalaiqu, Deane, Nawafleh, Clark and Gray 
(2010) state that only 50-70% of patients take their prescribed antihypertensive medications. 
There are likely many contributing factors implicated in adherence behaviours, such as 
complexity of medication regimes, socioeconomic status, patient demographics, side effects, 
knowledge and illness beliefs (Alhalaiqu et al., 2010; Aslam & Feldman, 2015). The complex 
issue of adherence behaviour undoubtedly influences the efficacious control of hypertension 
(Alhalaiqu et al., 2010).  Lack of control of blood pressure could give rise to unnecessary 
complications and increases in morbidity and mortality as highlighted in the landmark studies on 
blood pressure control, such as the SPRINT trial (The SPRINT research group, 2015).  
 Based on the two studies that explored medication adherence analyzed in this literature 
review, MI is likely a worthwhile counselling technique for medication adherence especially if 
related to perceived self-efficacy. Self-efficacy “refers to patients’ perception of their ability to 
	 50	
follow a treatment plan” (Aslam & Feldman, 2015, p. 327) and MI in this case can help a patient 
reach his or her own conclusions regarding the link between medication and health. The results 
of the two adherence studies (Ma et al., 2014; Ogedegbe et al., 2008) that overall support the use 
of treatment adherence modalities (one significantly and one non-significantly) mirror other 
areas of study specific to HIV patients and highly active antiretroviral therapy (HAART), which 
requires strict adherence of 95% of doses to be taken correctly (Rapid Response Service, 2014). 
For example, in a two-arm, randomized, controlled trial by Golin et al. (2006), 140 adults with 
HIV were randomized to either a MI-based intervention or an HIV informational control 
program to assess improvement of adherence to antiretroviral therapy. An analysis of the study 
data revealed an overall, albeit non-significant increase in medication adherence in the 
intervention group using MI, in contrast to an overall decrease in the control group. Another 
retrospective study examined an interdisciplinary HIV-adherence program that utilized 
pharmacists to deliver the MI intervention as well as electronic drug monitoring to 104 patients 
(Krummenacher, Cavassini, Bugnon & Schneider, 2011). An analysis of the study data showed 
high adherence rates with persistence of therapy at 87% and an overall increase in undetectable 
viral loads in patients.  
 In summary, MI and medication adherence is an important area of inquiry and requires 
more research into optimal technique, duration, and measurement tools. For example, some 
studies utilize objective measurement tools, such as the MEMS pill caps, whereas other studies 
rely on more subjective tools, such as patient diaries. Another important area of inquiry includes 
the intensification of medications and how complicating medication regimes by increasing 
dosages or adding medications may impact adherence behaviours. Despite the need for further 
research in this area, NPs could utilize adaptations of MI in clinical practice by exploring the 
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patient’s willingness to discuss the purpose of medication and the importance of adherence to 
medication regimes.  
 Dose Dependent Effects of MI. The clinical trials included in this literature review are all 
unique with regards to the delivery of the MI intervention. However, three randomized 
controlled trials looked specifically at the dose response of MI on measured outcomes 
(Hardcastle et al., 2013; Miura et al., 2004; Schoenthaler et al., 2015). All of these trials have 
similarities in that they provide written educational materials reinforcing lifestyle changes to the 
intervention groups. However, they differ with regards to the MI intervention: one trial offered 
up to five face-to-face counselling sessions of MI (Hardcastle et al., 2013); one offered a single 
counselling session versus an intervention of ten weekly classes followed by three individual MI 
sessions (Schoenthaler et al., 2015); and the last study offered six sessions of health counselling 
(Miura et al., 2004). The results of these trials are ambiguous as one study showed no significant 
effect on blood pressure outcomes (Hardcastle et al., 2013), while another indicated significant 
changes in both the high and low intervention groups with no significant difference between the 
two (Schoenthaler et al., 2015) and finally, the last trial showed significant difference in the MI 
group in comparison to usual care (Miura et al., 2004). An important factor in looking at these 
three trials specifically is that attendance was extremely variable. While this may mimic “real 
world” clinical practice, it makes it difficult to interpret which facets of these complex 
interventions are effective and give rise to improved clinical outcomes. For example, although 
the trial by Hardcastle et al. (2013) offered five sessions of MI, only a mean of two were 
attended. The trial by Schoenthaler et al. (2015) also had poor attendance specific to the high 
intervention arm and the trial by Miura et al. (2004) did not discuss attendance.  
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 In looking at other literature, one systematic review and meta-analysis by Rubak et al. 
(2005) included 72 randomized controlled trials on MI in many different areas of disease, such as 
addictions, psychiatric illness, asthma, and weight loss. Review criteria included randomized 
control trials that had some description of the methods and delivery of the MI intervention as 
well as utilizing traditional advice giving as the control. The authors found that longer MI 
encounters of 60 minutes were more effective than shorter MI encounters of less than 20 minutes 
(81% versus 64%) but the authors further state that MI can be effective in brief encounters of 15 
minutes and that more sessions attended increase the likelihood of effect. In contrast, a 
systematic review by Lundahl et al. (2013) critically appraised 51 studies utilizing MI as the 
intervention in medical settings. They reported that the number of MI sessions was unrelated to 
outcome. Further research that examine the impact of MI dose and duration of treatment would 
further solidify knowledge in this field and would provide important guidance for practitioners 
looking to integrate MI into their clinical practice.   
 Physician Adherence versus Patient Adherence. In this review, only one of the eight 
studies explored a physician quality control intervention, a patient lifestyle intervention and a 
combination of the two (Svetkey et al., 2009). This is an important area of inquiry because it 
acknowledges the responsibility of both the provider and the patient when working 
collaboratively towards a health goal. The results of this trial are interesting in that each 
intervention alone did not produce large reductions in blood pressure although the patient 
intervention group did reach a significant reduction of -2.6 mmHg systolic blood pressure. 
However, the combined intervention showed the greatest reduction in systolic blood pressure of -
9.7 mmHg +/- 12.7 mmHg highlighting a possible additive effect of provider adherence on 
patient adherence. In a related study that did not use MI, and was therefore not included in this 
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review, the analysis of the study findings revealed similar effects of a combined intervention 
(Roumie et al., 2006). In this study, three trial arms were compared: provider education; provider 
education and alert; and provider education and alert and patient education. The greatest effect 
was seen in the combined intervention arm of the trial where patients who achieved goal blood 
pressure reached significance (42% versus 40.9% versus 59.5%, p=0.003).  
 The above results of combined provider and patient interventions warrant further research 
into the potential additive effects on blood pressure. As stated above, combined interventions 
acknowledge the dual responsibility in the collaborative patient/provider relationship. Provider 
interventions may help to ensure that practitioners are utilizing evidence-based practice and thus 
providing optimal care to their patients. Unfortunately, the utilization of evidence-based 
guidelines in practice cannot be presumed. To highlight this, one study by Bell and Kravitz 
(2008) analyzed transcripts of audio-recorded outpatient visits to physicians and found that fewer 
than three out of ten patients were even given a blood pressure goal or given any information 
regarding the consequences of uncontrolled blood pressure or received any lifestyle counselling. 
Utilizing evidence-based practice is fundamental in primary care but especially vital to the NP 
profession that is establishing credibility and trust alongside patients and other health care 
professionals.  
 Discussion and Implications for Education. Core competencies of the NP role as set 
out by the College of Registered Nurses of British Columbia (2017) state that NP’s: 
“Advocate[s] for and create[s] an environment that facilitates learning and maximizes client 
participation and control of their own health, including living with chronic disease and meeting 
their own health needs” (p. 31). As such, MI would be a viable clinical model for NPs and other 
primary care providers and healthcare professionals to utilize in meeting competencies 
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associated with working in collaboration with patients and delivering patient-centered care. The 
formal inclusion of MI into healthcare professional education programs, including NP and 
medical education, would be one way to ensure that primary care professionals are adequately 
prepared for optimal use of this valuable technique. The need to attend to the theoretical 
components of MI is evident; however, in their book on MI, Miller and Rollnick (2002) caution 
that “a traditional training format is analogous to the very same expert model that we seek to 
avoid in our counselling” (p. 180). Instead they advocate learning from client interactions, role-
playing, practice and feedback. In addition, VanBuskirk and Wetherell (2014) further state that 
MI is not a cookie cutter set of techniques to be thrust upon patients but instead an approach that 
emphasizes patient expression of their own reasons for change through collaboration. Therefore, 
integrating the guiding principles of MI into healthcare professional education early on may be 
one way to ensure the seamless transition to utilizing MI in clinical behaviour change encounters. 
As NP students and other primary care trainees may not have the clinical experience to draw 
upon, MI skills could be taught with the goal that these skills form the basis of communication 
with patients throughout the student’s education and clinical practice. 
 Discussion and Implications for Research. Through this review, and the discussion of 
the findings with respect to its application to practice, a number of areas for further research have 
been identified. First, methodological variations, including the highly diverse dose and delivery 
of MI interventions weakens the evidence base and makes it challenging for providers to form 
judgements with respect to how to integrate MI into clinical practice. Variation in practice is 
evident in the literature with one large study evaluating performance on 439 indicators of quality 
of care for acute conditions, chronic conditions and preventive care (McGlynn et al., 2003). 
Results of this analysis illustrated that participants received 54.9 percent of recommended care 
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with little variation amongst acute versus chronic versus preventative care. When reviewing 
hypertension specifically, the authors stated that treatment, including lifestyle modification and 
medications, was underused (McGlynn et al., 2003). As discussed, provider quality control 
interventions would help ensure evidence-based practice is utilized leading to a decrease in 
variation in practice.  
  Second, a predominant goal of this literature review was to assess the efficacy of MI for 
hypertension in primary care settings, however many of the studies would be difficult to 
integrate into clinical practice in the primary care setting because of the study design, such as 
duration and frequency of intervention. As such, further research into clinically viable methods 
of delivering MI in the clinic setting is needed. Furthermore, to explore the use of MI specifically 
by primary care providers, research studies inclusive of NPs, would further contribute to the 
existing body of evidence.  
 Third, an appraisal of the studies illustrated that those, which include biometric 
measurements in addition to qualitative tools, achieved a more balanced and explanatory set of 
results. These were found to go beyond the traditional clinical outcomes to also include patient-
oriented outcomes and perspectives. Further research should strive to include quantitative and 
qualitative data that can expand our understanding of the impact of MI upon the management of 
hypertension. These should also include patient-oriented outcomes and perspectives, to examine 
the acceptability of these interventions, since this would impact upon the broader patient and 
clinical outcomes. Furthermore, including a patient lens is critical, particularly when looking at 
research within the context of visible minorities, which may have differing viewpoints of health.  
 Fourth, fidelity of MI technique is an important consideration when assessing research in 
this domain as the studies do variable jobs of reporting on it. Six of the eight studies do mention 
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some effort at fidelity measures, such as MI trainers reviewing videotaped sessions and 
providing feedback to the interventionists; however, none of the studies appear to utilize a 
treatment coding tool such as the MI Treatment Integrity Coding Manual 4.2.1 (Moyers, Manuel 
& Ernst, 2015). This tool consists of scales to assess the clinician’s MI skill and would therefore 
illuminate whether an intervention is in fact delivering what it seeks to. Interestingly, authors of 
one systematic review report that treatment fidelity is inversely proportional to effect size in their 
meta-analysis (Lundahl et al., 2013). They hypothesize that this could be due to interventions not 
actually being consistent with MI, or conversely that MI may be easier to implement than 
thought, discarding the theory that fidelity monitoring is necessary. Therefore, research into the 
necessity and development of fidelity tools when using MI as an intervention would help to 
establish clarity on whether researchers are actually delivering what they claim.  
 With regards to the Canadian context of this review, research on Indigenous Canadians, 
visible minorities, and immigrant populations would be salient as close to one-fifth of the 
Canadian population are members of a visible minority group (Khan, Kobayashi, Lee & Vang, 
2015). Furthermore, although research about visible minorities and health is lacking, it is known 
that certain ethnic groups have a susceptibility to hypertension above others (Khan et al., 2015). 
It is also well accepted that health discrepancies exist for Canadian Indigenous peoples compared 
to non-Indigenous Canadians with obesity, dyslipidemia, hypertension, and diabetes being 
common even in young adults (King, 2010). In one study by Bruce, Riediger, Zacharias and 
Young (2011) looking at obesity and related comorbidities in a Canadian First Nation population, 
22% of participants had undiagnosed hypertension and had subsequently significantly more 
chronic conditions including microalbuminuria.  
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 When viewing health disparities specific to Indigenous populations, it is vital that 
healthcare providers, educators, and organizations acknowledge and respect the work of the 
Truth and Reconciliation Commission of Canada (2015), which acknowledges that health 
disparities are “a direct result of previous Canadian government policies, including residential 
schools” (p. 322). Furthermore, one of the Commission’s calls to action specifies that medical 
and nursing programs be required to teach a course on Indigenous health issues requiring “skills-
based training in intercultural competency, conflict resolution, human rights, and anti-racism” (p. 
323). Incorporating this lens, along with MI, may further assist providers in caring for 
populations at risk, or suffering from, hypertension. 
 Research specific to the above visible minorities, is a necessity in order to acknowledge 
and examine the unique social determinants of health related to “cultures, histories and 
colonization, and the current social, economic, political and geographic context (King, 2010, 
para. 1). It is through this promotion of understanding of the unique challenges faced by 
minorities that development of appropriate and inclusive healthcare interventions that address 
disparities, promote equity and improve the health outcomes of all Canadians may occur.  
 In summary, key recommendations for clinical practice take into consideration that MI in 
the clinical setting related to hypertension requires more research into optimal dose, duration, 
method of delivery, and fidelity measures. Despite this, some key recommendations gained from 
this review support the utilization of MI or adaptations of MI into clinical practice as Rubak et al. 
(2005) state that no studies have reported any adverse effects or harm associated with MI.  MI in 
clinical practice may need to be an interdisciplinary process in order to overcome time 
constraints, or MI may be feasible in an NP’s practice, which may have greater flexibility with 
office appointment times. The utilization of behaviour change techniques, such as MI, by NPs 
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may help highlight the role’s unique contribution and value to the health care system. All of the 
studies included in this review are randomized controlled trials, and the addition of qualitative 
research regarding MI would add valuable data, such as patient perspectives into the MI 
literature.  Other key recommendations include the formal addition of MI into healthcare 
profession’s educational preparation in order to solidify a foundation of behaviour change 
techniques. Furthermore, regarding a Canadian context, education and research specific to 
Canadian Indigenous people and visible minorities is vital in understanding health issues facing 
many Canadians as well as supporting the health of all Canadians. Please see appendix 2 for a 
summary of recommendations.  
Limitations 
 Potential limitations of this review include the lack of literature related to the Canadian 
context. The studies included in this review vary regarding geographical location and ethnicity of 
participants and this should be acknowledged when applying findings within a Canadian context. 
Furthermore, while every attempt was made to undertake a thorough search, it is possible that 
some sources may have been overlooked. This review had a small number of studies included, 
given the inherent variation in the literature, and as a result it is challenging to make concrete 
recommendations for NP practice and thus further research in the field is needed to address these 
gaps.  
Conclusion 
 Hypertension is a chronic health condition that accounted for over 20 million patient 
visits to primary care clinics in 2007 (PHAC, 2010). Despite it being the most common reason to 
visit a physician, hypertension is often silent and has the potential to inflict serious organ damage 
on those who may not be aware that they have it (Hammer & McPhee, 2014). The costs to the 
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healthcare system, the economy, as well as on individual quality of life (WHO, 2013), 
necessitate research into the prevention and treatment of hypertension. Current evidence 
recommends the inclusion of lifestyle modifications for all hypertensive patients and lifestyle 
modification may be adequate treatment if it is caught in the early stages (Daskalopoulou et al., 
2015; James et al., 2014; World Health Organization, 2003). The focus of this literature review is 
therefore geared toward lifestyle modification in the context of hypertension in primary care 
which led to the inquiry: Is MI within a primary care context an effective method in eliciting 
change relating to modifiable risk factors associated with hypertension? In order to answer this 
inquiry a thorough literature search was conducted using the CINAHL, Medline OVID, 
PUBMED, and COCHRANE Reviews databases. A total of eight relevant articles were selected 
for inclusion. These articles were then critically reviewed using the CASP tools in order to 
highlight study strengths, weaknesses and overall findings. 
 Based on the critical analysis of the eight articles, key outcomes were revealed regarding 
the use of MI and hypertension. Overall, MI shows great potential in its utility in primary care 
for hypertensive patients with the majority of studies showing positive results on blood pressure. 
However, further research needs to be undertaken looking at uniformity of the MI intervention in 
order to establish clearer guidelines on optimal length and number of sessions; utilizing the 
primary care provider as the interventionist; and research on Indigenous populations and visible 
minorities.  Further research will help to establish the utility of MI in the clinical setting and thus 
provide primary care providers and patients a tool that can be learned and used with confidence 
when collaborating on behavioural change in the context of hypertension. 
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Appendix 1. Summary of Search Strategy Methodology 
Date Database Search Terms/ Boolean 
operator 
Results 
May 6, 2016 CINAHL Hypertension AND MI; 
AND cardiovascular risk 
factors 
29; 
4 
May 1st 2016 Medline OVID Hypertension AND MI; 
AND primary care 
Hypertension AND 
Cognitive therapy OR 
counselling AND 
primary healthcare 
14; 
3 
 
 
54 
May 6th 2016 PUBMED Hypertension OR 
Cardiovascular Disease 
AND MI; 
AND cardiovascular risk 
factors 
32; 
9 
June 13th, 2016 COCHRANE Hypertension AND MI; 
Hypertension AND MI 
AND nurse 
practitioners;  
Cardiovascular disease 
AND MI 
66; 
3; 
62 
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Appendix 2: Article Matrix 
 
Authors Title Methodological 
Approach 
Rationale for 
Inclusion/Exclusion 
Fisher, Fitzgibbon, 
Glasgow, Haire-
Joshu, Hayman, 
Kaplan, Nanney & 
Ockene (2011) 
Behaviour Matters: 
Summary of evidence 
Evidence summary Excluded: not a study 
and no focus on 
hypertension or MI 
Stenman, Leijon, 
Calling, Bergmark, 
Arvidsson, Gerdtham, 
Sundquist & Ekesbo 
(2012) 
Study Protocol: A 
Multi-profession team 
intervention of 
physical activity 
referrals in primary 
care patients with 
cardiovascular risk 
factors – the Dalby 
Lifestyle Intervention 
Cohort (DALICO) 
study: study protocol 
in 2012 
Randomized 
controlled trial 
Excluded: Study has 
not concluded as of 
yet 
Ogedegbe, Tobin, 
Fernandez, Cassells, 
Diaz-Gloster, 
Khalida, Pickering & 
Schwartz (2014) 
Counseling African 
Americans to Control 
Hypertension: 
Cluster-Randomized 
Clinical Trial Main 
Effects 
Cluster-randomized 
Clinical trial 
Excluded: 
Intervention not 
consistent with MI 
Svetkey, Pollak, 
Yancy, Dolor, Batch, 
Samsa, Matchar & 
Lin (2009) 
Hypertension 
Improvement Project: 
Randomized Trial of 
Quality Improvement 
for Physicians and 
Lifestyle Modification 
for Patients 
Randomized 
controlled trial 
Included: Stated the 
intervention was MI 
and was delivered by 
trained specialists 
Kastarinen, Puska, 
Korhonen, Mustonen, 
Salomaa, Sundvall, 
Tuomilehto, Uusitupa 
& Nissinen (2002) 
Non-pharmacological 
treatment of 
hypertension in 
primary health care: a 
2-year open 
randomized controlled 
trial of lifestyle 
intervention against 
hypertension in 
eastern Finland 
Randomized 
controlled trial 
Excluded: No 
correlation with MI 
Ruzicka, Hiremath, 
Steiner, Helis, 
What is the feasibility 
of implementing 
Systematic Review of 
6 trials 
Excluded: Does not 
identify counselling 
	 69	
Szczotka, Baker & 
Fodor (2014) 
effective sodium 
reduction strategies to 
treat hypertension in 
primary care settings? 
A systematic review 
methods as MI and 
states that none of the 
counselling methods 
were feasible for 
application in primary 
care settings 
Bell & Kravitz (2008) Physician counselling 
for hypertension: 
What do doctors 
really do? 
Qualitative analysis of 
transcripts of audio-
recorded outpatient 
visits, augmented with 
patient and physician 
surveys 
Excluded: as did not 
utilized MI as 
intervention or have 
BP as measurable 
outcome 
Hardcastle, Taylor, 
Bailey, Harley & 
Hagger (2013) 
Effectiveness of a MI 
intervention on weight 
loss, physical activity 
and cardiovascular 
disease risk factors: a 
randomised controlled 
trial with a 12-month 
post-intervention 
follow-up 
Randomized 
controlled trial 
Included: uses MI in 
primary care settings 
and BP is 
measureable outcome 
Schoenthaler, 
Luerassi, Teresi, 
Silver, Kong, 
Odedosu, Trilling, 
Errico, Uvwo, Sebek, 
Adekoya & Ogedegbe 
(2011) 
A practice-based trial 
of blood pressure 
control in African 
Americans (TLC-
Clinic): study protocol 
for a randomized 
controlled trial 
Randomized 
controlled trial 
Excluded: trial 
protocol 
Miura, Yamaguchi, 
Urata, Himeshima, 
Otsuka, Tomita, 
Yamatsu, Nishida & 
Saku (2004) 
Efficacy of a 
Multicomponent 
Program (Patient-
Centered Assessment 
and Counseling for 
Exercise plus 
Nutrition [PACE + 
Japan]) for Lifestyle 
Modification in 
Patients with Essential 
Hypertension 
Randomized 
Controlled Trial 
Included:  description 
of the characteristics 
of the counselling 
were deemed to be 
similar to MI 
Artinian et al. (2010) Interventions to 
promote physical 
activity and dietary 
lifestyle changes for 
cardiovascular risk 
factor reduction in 
adults: A scientific 
Scientific Statement Excluded: not a study 
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statement from the 
American Heart 
Association 
Campos-Outcalt 
(2014) 
Diet, exercise, and 
CVD: When 
counselling makes the 
most sense 
Practice Alert Excluded: not a study 
Niiranen, Leino, 
Puukka, Kantola, 
Karanko & Jula 
(2014) 
Lack of Impact of a 
Comprehensive 
Intervention on 
Hypertension in the 
Primary Care Setting 
Randomized 
Controlled Trial 
Excluded: the 
participants were 
instructed on how to 
change their diet, the 
amount of exercise 
and weight loss and 
alcohol use. Specific 
lifestyle goals were 
used. This is not 
consistent with MI 
and the authors do not 
state that MI was 
used. 
 
Roumie, Elasy, 
Greevy, Griffin, Liu, 
Stone, Wallston, 
Dittus, Alvarez, Cobb, 
Speroff (2006) 
Improving Blood 
Pressure Control 
through Provider 
Education, Provider 
Alerts, and Patient 
Education 
Cluster randomized, 
controlled trial 
Excluded: used 
patient education not 
MI 
Willard-Grace, Chen, 
Hessler, DeVore, 
Prado, Bodenheimer 
& Thom (2015) 
Health Coaching by 
Medical Assistants to 
Improve Control of 
Diabetes, 
Hypertension, and 
Hyperlipidemia in 
Low-Income Patients: 
A Randomized 
Controlled Trial 
Randomized 
controlled trial 
Included: Consistent 
with MI and BP 
measureable outcome 
Farrell & Keeping-
Burke (2014) 
The Primary 
Prevention of 
Cardiovascular 
Disease: Nurse 
Practitioners Using 
Behaviour 
Modification 
Strategies 
Opinion piece Excluded: not a study 
Tonstad, Alm & 
Sandvik (2007) 
Effect of nurse 
counselling on 
Randomised 
controlled trial 
Excluded: Based on 
behavioural self-
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metabolic risk factors 
in patients with mild 
hypertension: A 
randomised controlled 
trial 
management and the 
Transtheoretical 
Stages of Change. 
Nothing consistent 
with MI 
Ski & Thompson 
(2012) 
MI as a brief 
intervention to 
improve 
cardiovascular health 
Editorial Excluded: not a study 
Landry, Madson, 
Thomson, Zoellner, 
Connell & Yadrick 
(2015) 
A randomized trial 
using MI for 
maintenance of blood 
pressure 
improvements in a 
community-engaged 
lifestyle intervention: 
HUB city steps 
Randomized 
controlled trial 
Excluded: because it 
was performed by two 
MI coaches who were 
research staff and it 
was a community 
engaged lifestyle 
intervention. I 
wondered at its 
applicability to 
primary care as 
besides the telephone 
delivery of MI, 3 
health fairs were held 
at 3 month intervals. 
Drevenhorn, Bengtson 
& Kjellgren (2015) 
To be motivated or 
only comply – 
patients’ views of 
hypertension care 
after consultation 
training for nurses 
Elicited as part of a 
randomized controlled 
study 
Excluded: reports on 
patients’ perceptions 
on nurse management 
of hypertension. Does 
not use blood pressure 
as measurable 
outcome 
Woollard, Beilin, 
Lord, Puddey, 
MacAdam & Rouse 
(1995) 
A Controlled Trial of 
Nurse Counselling on 
Lifestyle Change For 
Hypertensives Treated 
in General Practice: 
Preliminary Results 
Randomized 
Controlled Trial 
Included: utilizes MI 
and BP as measurable 
outcome 
Volpp (2002) The Counseling 
African Americans to 
Control Hypertension 
Study and Ways to 
Enhance the Next 
Wave of Behavioural 
Interventions 
Editorial Excluded: editorial 
Schoenthaler, 
Luerassi, Silver, 
Odedosu, Kong, 
Comparative 
Effectiveness of a 
Practice-Based 
Randomized 
Controlled Trial 
Included: Uses MI 
and BP as 
measureable outcome 
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Ravenell, Teresi & 
Ogedegbe (2015) 
Comprehensive 
Lifestyle Intervention 
vs. Single Session 
Counseling in 
Hypertensive Blacks 
in primary care setting 
Ma, Zhou, Zhou & 
Huang (2014) 
Evaluation of the 
Effect of MI 
Counselling on 
Hypertension Care 
Randomized 
Controlled Trial 
Included: utilizes MI 
in primary care and 
BP as measurable 
outcome 
Hyman, Pavlik, 
Taylor, Moye (2007) 
Simultaneous vs. 
Sequential 
Counselling for 
Multiple Behaviour 
Change 
Randomized 
Controlled Trial 
Excluded: did not use 
BP as measurable 
outcome 
Blackford, Jancey, 
Lee, James, Howat, 
Hills & Anderson 
(2015) 
A Randomized 
Controlled Trial of a 
Physical Activity and 
Nutrition Program 
Targeting Middle-
aged Adults at Risk of 
Metabolic Syndrome 
in a Disadvantaged 
Rural Community 
Randomized 
controlled trial 
Excluded: Trial 
remains in progress 
Kouwenhoven-
Pasmooij, Djikanovic, 
Robroek, Helmhout, 
Burdorf & Hunink 
(2015) 
Design and Baseline 
Characteristics of the 
PerfectFit Study: A 
Multicenter Cluster-
randomized Trial of a 
Lifestyle Intervention 
in Employees with 
Increased 
Cardiovascular Risk 
Cluster Randomized 
Controlled Trial 
Excluded: Trial 
Remains in Progress 
Marquardt & Vezeau 
(2007) 
MI: The Link 
Between Healthy 
Choices and Healthy 
Patients 
Opinion Piece  Excluded: not a study 
Roberts & Ivey 
(2012) 
Is MI Effective For 
Hypertension? 
Opinion piece Excluded: not a study 
Van Keulen, Mesters, 
Ausems, Breukelen, 
Campbell, Resnicow, 
Brug, de Vries (2011) 
Tailored Print 
Communication and 
Telephone MI are 
Equally Successful in 
Improving Multiple 
Lifestyle Behaviours 
in a Randomized 
Controlled Trial:  
Randomized 
Controlled Trial 
Excluded: Did not use 
BP as a measurable 
outcome 
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Nolan, Liu, 
Shoemaker, 
Hachinski, Lynn, 
Mikulis, Wennberg, 
Moy & Zbib (2012) 
Therapeutic Benefit of 
Internet-Based 
Lifestyle Counselling 
for Hypertension: 
Randomized 
Controlled Trial 
Excluded: Electronic 
e-counselling and not 
MI 
Ren, Yang, Browning, 
Thomas & Liu (2014) 
Therapeutic Effects of 
MI on Blood Pressure 
Control: A Meta-
Analysis of 
Randomized 
Controlled Trials 
Meta-analysis of 
Randomized 
Controlled Trials 
Excluded: Not 
applicable to primary 
care setting 
Navidian, Abedi, 
Baghban, Fatehizadeh 
& Poursharifi (2010) 
Effect of MI on Blood 
Pressure of Patients 
Suffering From 
Hypertension 
Quasi-experimental 
study - Randomized 
Excluded: Purely 
Group MI so question 
applicability to 
primary care 
Tan & Morgan (2015) Psychological 
Interventions in 
Cardiovascular 
Disease: An Update 
Review Article Excluded: not a study 
and did not focus on 
MI or BP 
VanBuskirk & 
Wetherell (2014) 
MI With Primary 
Care Populations: A 
Systematic Review 
and Meta-analysis 
Systematic Review 
and Meta-analysis 
Excluded: Looked at 
10 studies using MI 
but only one focused 
on hypertension 
Rubak, Sandboek, 
Lauritzen & 
Christensen (2005) 
MI: A Systematic 
Review and Meta-
analysis 
Systematic Review 
and Meta-analysis 
Excluded: Looked at 
72 randomized 
controlled trials 
focused on different 
areas of disease 
Lundahl, Moleni, 
Burke, Butters, 
Tollefson, Butler & 
Rollnick (2013) 
MI in Medical Care 
Settings: A 
Systematic Review 
and Meta-analysis of 
Randomized 
Controlled Trials 
Systematic Review 
and Meta-analysis 
Excluded: Looked at 
48 studies of varying 
diseases. Only two 
studies used BP as a 
measurable outcome 
Ogedegbe, Chaplin, 
Schoenthaler, 
Statman, Berger, 
Richardson, Phillips, 
Spencer & Allegrante 
(2008) 
A Practice-based Trial 
of MI and Adherence 
in Hypertensive 
African Americans 
Randomized 
Controlled Trial 
Included: Utilized MI 
and BP as 
measureable outcome 
in Primary Care 
Hartley & Repede 
(2011) 
Nurse Practitioner 
Communication and 
Treatment Adherence 
in Hypertensive 
Patients 
Opinion piece Excluded: Not a 
study. Does not 
discuss MI but 
discusses patient-
centered outcomes 
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Appendix Three: Summary of Recommendations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinical	Recommendations:	
• An	interdisciplinary	approach	utilizing	MI	into	clinical	practice	may	help	overcome	difficulties	with	potential	time	constraints	of	using	this	approach	
• NPs	are	in	a	prime	position	to	incorporate	MI	into	practice	due	to	their	holistic	focus	on	health	promotion	and	prevention,	longitudinal	relationships	with	patients	and	longer	than	average	consultation	times	
• NPs	should	harness	their	capacity	to	provide	behavioural	change	counselling,	such	as	MI	in	order	to	illustrate	their	unique	contribution	and	value	to	the	healthcare	system	
• MI	shows	promise	regarding	medication	adherence	but	requires	more	research	into	optimal	technique,	duration,	and	measurement	tools.	NPs	may	use	MI	or	adaptation	of	MI	to	help	explore	importance	of	medication	adherence	and	health	
• Healthcare	provider	adherence	to	evidence-based	guidelines	combined	with	patient	adherence	likely	has	an	additive	effect	on	blood	pressure	reduction	and	ensures	optimal	delivery	of	healthcare	Educational	Recommendations:	
• A	combination	of	formal	education	and	learning	based	on	client	interactions,	role-playing,	practice	and	feedback	could	facilitate	MI	to	be	a	viable	clinical	model	utilized	by	primary	care	practitioners	
• Health	care	professional	education	programs	should	be	required	to	teach	courses	in	Indigenous	health	issues	including	history	of	colonization	and	residential	schools	Research	Recommendations:	
• Further	research	into	clinically	viable	methods	of	delivering	MI	in	the	clinic	setting	is	needed	with	a	focus	on	utilizing	the	primary	care	provider	as	the	interventionist	
• Research	that	includes	biometric	measures	in	addition	to	qualitative	tools	achieve	a	more	balanced	and	explanatory	set	of	results	including	patient-oriented	outcomes	and	perspectives	
• Potential	benefits	of	treatment	fidelity	protocols	needs	to	be	established	as	fidelity	is	not	uniform	in	current	research	
• Research	specific	to	Indigenous	people	and	visible	minorities	is	vital	to	address	disparities	in	health	and	promote	intercultural	understanding,	and	anti-racism	and	overall	improve	health	outcomes	of	all	Canadians	
